Endocrine Abstracts

Contents

• 26th European Congress of Endocrinology 2024
• • Prize Lectures
  • The Geoffrey Harris Award Lecture
  • • Abstract unavailable

      ea0099ap1
  • The European Journal of Endocrinology Award Lecture
  • • Abstract unavailable

      ea0099ap2
  • Clinical Endocrinology Journal Foundation Award Lecture
  • • Abstract unavailable

      ea0099ap3
  • European Hormone Medal Award Lecture
  • • Abstract unavailable

      ea0099ap4
  • The Transatlantic Alliance Award Lecture
  • • Abstract unavailable

      ea0099ap5
  • Jens Sandahl Christiansen Awards
  • • Abstract unavailable

      ea0099jsc1.1
    • Abstract unavailable

      ea0099jsc1.2
• Plenary Lectures
• • Hypoxia
  • • Abstract unavailable

      ea0099pl1
  • The clinical importance of high resolution, automated, ambulatory measurement of tissue steroids
  • • Abstract unavailable

      ea0099pl2
  • The Silent Decline: Unlocking the Enigma of Dropping Sperm Counts and Fertility Rates
  • • Abstract unavailable

      ea0099pl3
  • From molecular biology to precision medicine in endocrine tumors: Are we there yet?
  • • Abstract unavailable

      ea0099pl4
  • Machine Learning Based Data Analysis in Endocrinology
  • • Abstract unavailable

      ea0099pl5
  • Focus on the pancreas
  • • Abstract unavailable

      ea0099pl6
• Symposia
• • Craniopharyngioma: Pathogenesis and novel targeted treatments
  • • Abstract unavailable

      ea0099s1.1
    • Abstract unavailable

      ea0099s1.2
    • Abstract unavailable

      ea0099s1.3
  • Thyroid hormones and development
  • • Abstract unavailable

      ea0099s2.1
    • Abstract unavailable

      ea0099s2.2
    • Abstract unavailable

      ea0099s2.3
  • Neural pathways controlling feeding behaviour: impact of circulating hormones
  • • Amylin - an anorexigenic pancreas-brain signal

      ea0099s3.1
    • Abstract unavailable

      ea0099s3.2
    • Abstract unavailable

      ea0099s3.3
  • Osteoporosis Conundrums
  • • Abstract unavailable

      ea0099s4.1
    • Abstract unavailable

      ea0099s4.2
    • Symposium: 'Does sclerostin inhibition increase cardiovascular risk?'

      ea0099s4.3
  • Emerging aspects of menopause
  • • Abstract unavailable

      ea0099s5.1
    • Abstract unavailable

      ea0099s5.2
    • Abstract unavailable

      ea0099s5.3
  • New applications of Steroid Hormones
  • • Abstract unavailable

      ea0099s6.1
    • Abstract unavailable

      ea0099s6.2
    • Novel forms of adrenal insufficiency

      ea0099s6.3
  • What‗s new in metabolic-associated fatty liver disease?
  • • Abstract unavailable

      ea0099s7.1
    • Abstract unavailable

      ea0099s7.2
    • Abstract unavailable

      ea0099s7.3
  • Novel pathological aspects of adipose tissue
  • • A macrophage-collagen fragment axis in the regulation of adipose tissue functionality

      ea0099s8.1
    • Abstract unavailable

      ea0099s8.2
    • Abstract unavailable

      ea0099s8.3
  • Microscopic companions of the endocrine system
  • • Abstract unavailable

      ea0099s9.1
    • Abstract unavailable

      ea0099s9.2
    • Abstract unavailable

      ea0099s9.3
  • Bone and muscle vitamin replacement
  • • Abstract unavailable

      ea0099s10.1
    • Abstract unavailable

      ea0099s10.2
    • Abstract unavailable

      ea0099s10.3
  • Recent studies that changed my practice
  • • Abstract unavailable

      ea0099s11.1
    • Abstract unavailable

      ea0099s11.2
    • Abstract unavailable

      ea0099s11.3
  • Senescence-mediated signalling in the pathogenesis of endocrine-related cancer: Pathogenesis and novel therapeutic opportunities
  • • Abstract unavailable

      ea0099s12.1
    • Abstract unavailable

      ea0099s12.2
    • Abstract unavailable

      ea0099s12.3
  • From reproduction to male contraception
  • • Abstract unavailable

      ea0099s13.1
    • Abstract unavailable

      ea0099s13.2
    • Abstract unavailable

      ea0099s13.3
  • Endocrine disruption – from bench to bedside
  • • Abstract unavailable

      ea0099s14.1
    • Abstract unavailable

      ea0099s14.2
    • Abstract unavailable

      ea0099s14.3
  • Genetics and molecules in pituitary tumours
  • • Abstract unavailable

      ea0099s15.1
    • Abstract unavailable

      ea0099s15.2
    • Abstract unavailable

      ea0099s15.3
  • The role of muscle in metabolic diseases
  • • Abstract unavailable

      ea0099s16.1
    • Abstract unavailable

      ea0099s16.2
    • Abstract unavailable

      ea0099s16.3
  • Advances in the management of adrenocortical carcinoma
  • • Abstract unavailable

      ea0099s17.1
    • Abstract unavailable

      ea0099s17.2
    • Abstract unavailable

      ea0099s17.3
• Joint Sessions
• • Joint Session 1: ESE and the European Society of Endocrine Surgeons
  • • Abstract unavailable

      ea0099js1.1
  • Joint Session 2: ESE and European Society of Paediatric Endocrinology
  • • Abstract unavailable

      ea0099js2.1
    • Abstract unavailable

      ea0099js2.2
  • Joint Session 3: ESE and the Korean Endocrine Society – Mild autonomous cortisol secretion (MACS): new insights from European and Korean studies
  • • Abstract unavailable

      ea0099js3.1
    • Abstract unavailable

      ea0099js3.2
    • Abstract unavailable

      ea0099js3.3
  • Joint Session 4: European Society of Endocrinology and the SBEM, FASEN, SMNE (Central/South America societies)
  • • Abstract unavailable

      ea0099js4.1
    • Abstract unavailable

      ea0099js4.2
    • Abstract unavailable

      ea0099js4.3
  • Joint Session 5: European Society of Endocrinology and the Androgen Excess and PCOS Society
  • • Abstract unavailable

      ea0099js5.1
    • Abstract unavailable

      ea0099js5.2
    • Abstract unavailable

      ea0099js5.3
• EYES Symposium
• • Section
  • • Abstract unavailable

      ea0099eyes1
• ECAS Symposium
• • Section
  • • Abstract unavailable

      ea0099ecas1
• New Scientific Approaches
• • Insights into Endocrine Pathology: What Does the Endocrinologist Need to Know?
  • • Abstract unavailable

      ea0099nsa1
  • Methylomics in aggressive pituitary tumours
  • • Abstract unavailable

      ea0099nsa2
  • Artificial intelligence in Endocrinology
  • • Abstract unavailable

      ea0099nsa3
• Debate Sessions
• • Bone biomarkers – helpful for decisions in osteoporosis patients?
  • • Abstract unavailable

      ea0099d1.1
    • Abstract unavailable

      ea0099d1.2
  • Pituitary tumours: Should Cavernous sinus invasion be removed
  • • Abstract unavailable

      ea0099d2.1
    • Abstract unavailable

      ea0099d2.2
  • Active surveillance of thyroid cancer FOR or AGAINST
  • • Abstract unavailable

      ea0099d3.1
    • Abstract unavailable

      ea0099d3.2
• Meet the Expert Basic Scientist Sessions
• • Human adrenal development
  • • Abstract unavailable

      ea0099mtebs1
  • Identifying new receptors in the regulation of fertility
  • • Abstract unavailable

      ea0099mtebs2
  • In vitro cellular reprogramming to model gonad development and its disorders
  • • Abstract unavailable

      ea0099mtebs3
• Meet The Expert Sessions
• • Osteoporosis in advanced chronic kidney disease
  • • Abstract unavailable

      ea0099mte1
  • Radiotherapy/radiosurgery for pituitary tumours; long term outcome and consequences
  • • Abstract unavailable

      ea0099mte2
  • Estogen & immune micro environment in tumour progression
  • • Abstract unavailable

      ea0099mte3
  • The HPA axis response to critical illness
  • • The HPA axis response to critical illness

      ea0099mte4
  • Paediatric concerns of endocrine disruptors
  • • Abstract unavailable

      ea0099mte5
  • Female infertility
  • • Abstract unavailable

      ea0099mte6
  • Management of Functional Pancreatic Neuroendocrine Neoplasms
  • • Abstract unavailable

      ea0099mte7
  • Primary Hyperparathyroidism 2024: What‗s new and Further Perspectives
  • • Abstract unavailable

      ea0099mte8
  • Update on the management of Graves Disease
  • • Abstract unavailable

      ea0099mte9
  • How to prevent weight regain?
  • • Abstract unavailable

      ea0099mte10
  • Management of malignant pheochromocytoma
  • • Abstract unavailable

      ea0099mte11
• Pre-Congress Course
• • Androgen Excess and PCOS Society (AEPCOS) Update Meeting
  • • Abstract unavailable

      ea0099pcc1.1
    • Abstract unavailable

      ea0099pcc1.2
    • Abstract unavailable

      ea0099pcc1.3
    • Abstract unavailable

      ea0099pcc1.4
    • Abstract unavailable

      ea0099pcc1.5
    • Abstract unavailable

      ea0099pcc1.6
    • Abstract unavailable

      ea0099pcc1.7
    • Abstract unavailable

      ea0099pcc1.8
    • Abstract unavailable

      ea0099pcc1.9
  • Growth Hormone Research Society (GRS) Congress (Day1)
  • • Abstract unavailable

      ea0099pcc2.1
    • Abstract unavailable

      ea0099pcc2.2
    • Abstract unavailable

      ea0099pcc2.3
    • Abstract unavailable

      ea0099pcc2.4
    • Growth hormone, mini-mice, football, dirty shorts, and a new drug

      ea0099pcc2.5
    • Abstract unavailable

      ea0099pcc2.6
  • Growth Hormone Research Society (GRS) Congress (Day2)
  • • Abstract unavailable

      ea0099pcc3.1
    • Abstract unavailable

      ea0099pcc3.2
    • Abstract unavailable

      ea0099pcc3.3
    • Abstract unavailable

      ea0099pcc3.4
  • Thyroid Ultrasound Practical Course
  • • Abstract unavailable

      ea0099pcc4.1
    • Abstract unavailable

      ea0099pcc4.2
    • Abstract unavailable

      ea0099pcc4.3
    • Abstract unavailable

      ea0099pcc4.4
    • Abstract unavailable

      ea0099pcc4.5
    • Abstract unavailable

      ea0099pcc4.6
  • European Academy of Andrology (EAA) pre-congress course
  • • Abstract unavailable

      ea0099pcc5.1
    • Abstract unavailable

      ea0099pcc5.2
    • Abstract unavailable

      ea0099pcc5.3
    • Abstract unavailable

      ea0099pcc5.4
    • Abstract unavailable

      ea0099pcc5.5
• Nurse Sessions
• • Precision Medicine: Thyroid Disorder
  • • Abstract unavailable

      ea0099n1.1
    • Abstract unavailable

      ea0099n1.2
    • Abstract unavailable

      ea0099n1.3
  • Precision Medicine: Craniopharyngioma
  • • Abstract unavailable

      ea0099n2.1
    • Abstract unavailable

      ea0099n2.2
    • Abstract unavailable

      ea0099n2.3
  • How to Workshop
  • • Abstract unavailable

      ea0099n3.1
    • Abstract unavailable

      ea0099n3.2
    • Abstract unavailable

      ea0099n3.3
  • Endocrine Nurse Achievement Session
  • • Abstract unavailable

      ea0099n4.1
    • Abstract unavailable

      ea0099n4.2
    • Abstract unavailable

      ea0099n4.3
• Oral Communications
• • Oral Communications 1: Reproductive and Developmental Endocrinology
  • • Hypospadias is linked to genetic susceptibility to the environment through oncogenes and its incidence is geographically correlated to that of cancers worldwide

      ea0099oc1.1
    • Mortality among women with POI, nationwide register based case-control study

      ea0099oc1.2
    • Pregnancy loss in women with endocrine disorders - a nationwide registry-based cohort study of 366,548 Danish women

      ea0099oc1.3
    • Kisspeptin as a test of hypothalamic function in women presenting with oligo / amenorrhoea

      ea0099oc1.4
    • Gender affirming treatment and employment rate in 3,812 Danish transgender persons and 38,120 controls. A nationwide register-based cohort study

      ea0099oc1.5
    • Sertoli cell function and the dose of denosumab is critical for the response to RANKL inhibition in human testis cultures

      ea0099oc1.6
  • Oral Communications 2: Calcium and Bone | Part I
  • • Encaleret (CLTX-305) sustained normalization of mineral homeostasis in patients with autosomal dominant hypocalcemia type 1 over 18 months in a phase 2 study [NCT04581629]

      ea0099oc2.1
    • Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway trial

      ea0099oc2.2
    • A translational approach to investigate the mechanism whereby eneboparatide induces prolonged calcium normalization in patients with chronic hypoparathyroidism

      ea0099oc2.3
    • Increased urinary excretion of calcium and nephrolithiasis: Real-life data from the epi-hypo cohort of hypoparathyroidism patients

      ea0099oc2.4
    • Remaining secretion of parathyroid hormone is associated with calcium excretion in chronic hypoparathyroidism

      ea0099oc2.5
    • CALIBRATE: A phase 3, randomized, open-label study evaluating the efficacy and safety of encaleret (CLTX-305) compared to standard of care in participants with autosomal dominant hypocalcemia type 1 [NCT05680818]

      ea0099oc2.6
  • Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I
  • • Long-term incidence of acute cardiovascular events in transgender people - a large cohort study with national registry data

      ea0099oc3.1
    • Copeptin and asymptomatic arterial disorder in patients with type 2 diabetes, a cross-sectional study

      ea0099oc3.2
    • Inflammation-based scores in patients with pheochromocytoma

      ea0099oc3.3
    • HHEX is required for maintaining circulating glucocorticoid levels through expression of steroid transporter ABCB1 and regulation of lipid droplet homeostasis in the adrenal cortex

      ea0099oc3.4
    • Hip fractures in patients with primary aldosteronism - A Swedish nationwide study

      ea0099oc3.5
    • Multiple dosing of immediate-release hydrocortisone is associated with a greater risk of hypothalamic-pituitary-adrenal axis suppression when compared to low-dose prednisolone when weaning in steroid-induced adrenal insufficiency

      ea0099oc3.6
  • Oral Communications 4: Diabetes, Obesity, Metabolism and Nutrition | Part I
  • • Glucose-loaded dopamine transporter is associated with mood altering effect of sweet foods and control over eating sweets

      ea0099oc4.1
    • Glucose at gestational diabetes diagnosis predicts neonatal hypoglycaemia, large-for-gestational age and post-partum abnormal maternal glucose homeostasis

      ea0099oc4.2
    • Nitrate-mediated dilation is impaired in people with type 1 diabetes and co-existent metabolic dysfunction-associated steatotic liver disease

      ea0099oc4.3
    • Sphinganine increases GLP-1 secretion and causes weight loss in mice

      ea0099oc4.4
    • Characteristics of presentation and management of people admitted with severe hypoglycaemia highlight the need for targeted educational interventions to mitigate occurrences-Pilot data from DEKODE Hypoglycaemia study

      ea0099oc4.5
    • GSDME Deficiency Sensitizes Mice to Diet-Induced Obesity by suppressing Lipolysis

      ea0099oc4.6
  • Oral Communications 5: Pituitary and Neuroendocrinology | Part I
  • • Effects of Glucagon-like Peptide-1 Receptor Agonists on Copeptin in healthy volunteers and patients with primary polydipsia-A secondary analysis of the randomized, double-blind, placebo-controlled, crossover GOLD & GATE trials

      ea0099oc5.1
    • Molecular and functional characterization of RNA metabolism machineries in pituitary tumours

      ea0099oc5.2
    • Transcriptomics analysis confirms WHO classification of PitNETs and reveals distinct patterns related to invasiveness

      ea0099oc5.3
    • Mast cells, a new actor in gonadotroph tumors

      ea0099oc5.4
    • B-RAF and MEK inhibitor argeted therapy in papillary craniopharyngiomas: results from the French national multicenter study

      ea0099oc5.5
    • Digital voice analysis as a biomarker for acromegaly

      ea0099oc5.6
  • Oral Communications 6: Environmental Endocrinology
  • • Higher PFOS exposure associated with higher SHBG in third trimester. The odense child cohort

      ea0099oc6.1
    • Thyroid Cancer and Endocrine Disruptive Chemicals: A Case-Control Study on Persistent Organic Pollutants (POPs)

      ea0099oc6.2
    • NRF2 genetic polymorphisms modify the longitudinal association of serum polychlorinated biphenyls with glucose homeostasis damage: A gene-environment interaction analysis among Chinese general adults

      ea0099oc6.3
    • 1,25-Dihydroxyvitamin D3 reduces adipogenesis and mitigates the bisphenol-A-induced pro-adipogenic effect in mouse 3T3-L1 cell line and human adipose-derived mesenchymal stem cells through miR-27-3p regulation

      ea0099oc6.4
    • Assessing the interaction of styrene/ethylbenzene exposure with genetic susceptibility in type 2 diabetes mellitus: insights from a cohort study

      ea0099oc6.5
    • Active smoking is associated with hypercortisolism in adrenal tumors: A large cross-sectional study

      ea0099oc6.6
  • Oral Communications 7: Endocrine-related Cancer
  • • CRISPR/Cas9-mediated glucocorticoid receptor knockout effectively enhances antitumor efficacy of ROR1 specific CAR-T cells in advanced adrenocortical carcinoma

      ea0099oc7.1
    • [177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: Primary analysis of the phase 3 randomized NETTER-2 study

      ea0099oc7.2
    • How close we are to optimise the assessment of SSTR status in NEN with a radiolabelled SSTR antagonist-final results of the TECANT clinical trial: Novel 99mTc-labelled somatostatin antagonists in the diagnostic algorithm of neuroendocrine neoplasms

      ea0099oc7.3
    • Single-nucleus atlas of adrenocortical carcinoma reveals tumor ecotypes associated with outcome

      ea0099oc7.4
    • Characterization and targeting of serpins alteration in chronic liver disease and hepatocellular carcinoma

      ea0099oc7.5
    • Whole-exome sequencing of atypical parathyroid tumors identifies novel genes and mutations in common with benign and malignant parathyroid tumors

      ea0099oc7.6
  • Oral Communications 8: Thyroid
  • • Autonomous AI-based diagnostic system for predicting malignancy in thyroid nodules

      ea0099oc8.1
    • Antigen-specific peptide immunotherapy attenuates the pathogenic response in a murine model of Graves' disease

      ea0099oc8.2
    • Magnetic resonance imaging characteristics of Graves orbitopathy with elevated IgG4 serum concentration

      ea0099oc8.3
    • The significance of 3-nitrotyrosine quantification in angioinvasive papillary thyroid carcinoma

      ea0099oc8.4
    • "Epithelial and stromal landscape heterogeneity at spatial resolution in autoimmune thyroid diseases"

      ea0099oc8.5
    • Filamin A is required for RET expression and signaling in medullary thyroid carcinoma (MTC) cells

      ea0099oc8.6
  • Oral Communications 9: Pituitary and Neuroendocrinology | Part II
  • • Differential gene expression in dopamine agonist sensitive and resistant human prolactinomas

      ea0099oc9.1
    • Successful breastfeeding in a parturient with panhypopituitarism: A case report and literature review with implications for endocrine practice

      ea0099oc9.2
    • Loss of heterozygosity predicts treatment-refractory behavior in pituitary neuroendocrine tumors

      ea0099oc9.3
    • Kisspeptin administration does not alter anxiety or circulating cortisol levels in humans

      ea0099oc9.4
    • Defining the role of androgen signalling in GABA neurons in the development of PCOS-like traits

      ea0099oc9.5
    • Antiproliferative role of the vasopressin V2 receptor antagonist tolvaptan in a murine xenograft model of small cell lung cancer

      ea0099oc9.6
  • Oral Communications 10: Calcium and Bone | Part II
  • • Time to severe chronic kidney disease and nephrolithiasis in hypoparathyroidism: results from a large longitudinal retrospective study

      ea0099oc10.1
    • The effect of gender affirming hormone therapy on calcium-phosphate homeostasis in transgender persons

      ea0099oc10.2
    • Calcium to magnesium ratio can be a new marker for predicting nephrolithiasis in patients with primary hyperparathyroidism

      ea0099oc10.3
    • Morning urinary Calcium/Creatinine Ratio as screening tool for hypercalciuria in patients with hypoparathyroidism

      ea0099oc10.4
    • The utility of contrast-enhanced ultrasound (CEUS) in the preoperative localization of parathyroid gland adenomas

      ea0099oc10.5
    • Efficacy of a computerized therapeutic decision-making algorithm in a Fracture Liaison Service targeting hip fracture patients

      ea0099oc10.6
  • Oral Communications 11: Adrenal and Cardiovascular Endocrinology | Part II
  • • Germline DNA methylation analysis reveals distinct alterations in a large cohort of patients with germline SDHB pathogenic variant

      ea0099oc11.1
    • Characterization of the interplay between the neuroendocrine stress axes and metabolic diseases

      ea0099oc11.2
    • Prediction of adrenal masses nature through texture analysis and deep learning: Preliminary results from ENS@T RADIO-AI multicentric study

      ea0099oc11.3
    • Machine learning-based differentiation of uni- and bilateral primary aldosteronism using circulating microRNA combinations

      ea0099oc11.4
    • Results of systematic KDM1A genotyping in a large series of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) patients and analysis of the genotype/phenotype correlation

      ea0099oc11.5
    • FKBP5 methylation in adrenal insufficiency: New insights into assessing the quality of glucocorticoid replacement

      ea0099oc11.6
  • Oral Communications 12: Diabetes, Obesity, Metabolism and Nutrition | Part II
  • • Loss of murine Gpr45 leads to significant obesity due to hyperphagia and hypoactivity

      ea0099oc12.1
    • Intestinimonas butyriciproducens as a new preventive therapy for type 2 diabetes: a proof of concept randomized controlled trial

      ea0099oc12.2
    • Growth hormone promotes in-vivo hepatic triglyceride export in humans

      ea0099oc12.3
    • Characteristics and outcomes of DKA in people taking SGLT2 inhibitors: DEKODE study

      ea0099oc12.4
    • The effects of semaglutide vs testosterone replacement therapy on functional hypogonadism and sperm quality in men with type 2 diabetes mellitus and obesity

      ea0099oc12.5
    • Efficacy and safety of postbiotic supplementation for type 2 diabetes patients: Randomized clinical Ttrial (DELI Diab study)

      ea0099oc12.6
  • Oral Communications 13: Late Breaking
  • • BCL2 expression is enriched in androgen receptor-negative advanced prostate cancer:

      ea0099oc13.1
    • Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: Serum and skeletal muscle profile

      ea0099oc13.2
    • Circulating CircRNAs for early diagnosis and prediction of gdm and their impact on trophoblast cell function

      ea0099oc13.3
    • Protective effect of growth hormone-releasing hormone (GHRH) and its agonistic analog MR-409 in Alzheimer's disease

      ea0099oc13.4
    • Use of thiazide diuretics in hypoparathyroidism: indication and effects

      ea0099oc13.5
    • Growth hormone-releasing hormone (GHRH) promotes transdifferentiation of myoblasts and white adipocytes into brown/beige adipocytes

      ea0099oc13.6
• Rapid Communications
• • Rapid Communications 1: Reproductive and Developmental Endocrinology
  • • Comparative study of the legal framework for the medical care of people with differences of sex developmental (DSD) across the world

      ea0099rc1.1
    • Endometrial transcriptome alterations following short-term liraglutide treatment in infertile women with polycystic ovary syndrome and obesity

      ea0099rc1.2
    • Clinical and genetic characterization of a large cohort of patients with premature ovarian failure

      ea0099rc1.3
    • The role of rare human PROK2/R2 mutations in the reproductive and metabolic health of the general population: A recall-by-genotype study

      ea0099rc1.4
    • Characterization of the role of LEAP-2 in the metabolic control of puberty

      ea0099rc1.5
    • The prevalence of serious autoimmune diseases is increased in women with premature ovarian insufficiency in Finland - A population-based study

      ea0099rc1.6
    • Characterisation of the daily rhythm of salivary androgens in healthy women and in women with polycystic ovary syndrome by liquid chromatography-tandem mass spectrometry

      ea0099rc1.7
  • Rapid Communications 2: Calcium and Bone | Part I
  • • Genetics of congenital hypoparathyroidism and pseudohypoparathyroidism: results of a multigenic screening in an Italian cohort of affected patients

      ea0099rc2.1
    • Irisin levels are correlated with age and behavioural performance in Post-surgical HypoPT condition

      ea0099rc2.2
    • Metformin prevents glucocorticoid-induced bone resorption in healthy subjects

      ea0099rc2.3
    • Primary hyperparathyroidism in children and adolescents: Clinical features and treatment outcomes from an Italian multicenter study

      ea0099rc2.4
    • Genetic testing for syndromic conditions in patients referred with primary hyperparathyroidism: a retrospective observational analysis

      ea0099rc2.5
    • Role of FGF23 in patients with transfusion-dependent [beta]-thalassemia and hypercalciuria

      ea0099rc2.6
  • Rapid Communications 3: Adrenal and Cardiovascular Endocrinology | Part I
  • • Biochemical control with dose reduction in chronic glucocorticoid therapy over 4 years: A phase III extension study of Chronocort (Efmody) in the treatment of Congenital Adrenal Hyperplasia (CAH)

      ea0099rc3.1
    • Combined [18F]Fluorodeoxyglucose PET and [123I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias - The prospective cross-sectional diagnostic test performance study FAMIAN

      ea0099rc3.2
    • Quantifying variability in ambulatory 24-hour tissue hormones for personalised management of hormonal replacement in patients with adrenal insufficiency

      ea0099rc3.3
    • CHAMPAIN study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency

      ea0099rc3.4
    • The saline infusion test with mass spectrometric measurements of aldosterone in patients tested for primary aldosteronism

      ea0099rc3.5
    • Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma: Diagnosis, prevalence, and clinical impact

      ea0099rc3.6
    • Factors that influence pheochromocytoma penetrance in MEN2A Syndrome

      ea0099rc3.7
  • Rapid Communications 4: Diabetes, Obesity, Metabolism and Nutrition | Part I
  • • Baseline hormonal profiling and post-surgical outcomes in patients with obesity undergoing bariatric surgery: Results from the novara experience

      ea0099rc4.1
    • Dysregulation of RNA-Exosome machinery in MASLD-HCC progression

      ea0099rc4.2
    • Irrespective of diet composition, cycles of low-calorie intake imprint a unique hepatic signature throughout the secretome to influence organismal energy balance

      ea0099rc4.3
    • The beta-2-adrenoreceptor agonist fenoterol increases resting enery expenditure without activation of brown adipose tissue in humans

      ea0099rc4.4
    • Precision medicine in type 2 diabetes mellitus: Unraveling the role of TCF7L2, CTRB1/2, and GLP-1R genetic variants in response to treatment with glucagon-like peptide-1 receptor agonists

      ea0099rc4.5
  • Rapid Communications 5: Pituitary and Neuroendocrinology | Part I
  • • Clinical use of 18F-fluoro-ethyl-tyrosine PET co-registered with MRI for diagnostic dilemmas in prolactinoma

      ea0099rc5.1
    • Lanreotide in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma (GALANT study): A randomised, double-blind, placebo-controlled trial

      ea0099rc5.2
    • Hypogonadotropic hypogonadism in patients with non-functioning pituitary adenomas before and after transsphenoidal surgery - A prospective study

      ea0099rc5.3
    • A phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AZP-3813, a novel, small peptide growth hormone receptor antagonist, in healthy subjects

      ea0099rc5.4
    • CRH-stimulated oxytocin in patients with hypopituitarism and hypothalamic damage: A randomized, single-blind, crossover, placebo-controlled trial

      ea0099rc5.5
    • Etiology, treatment, and outcomes of sellar metastases: A single-center institutional experience

      ea0099rc5.6
    • Changes of hepatic metabolism and lipidomic profile with biochemical improvement of acromegaly

      ea0099rc5.7
    • Outcomes of transsphenoidal surgery for producing pituitary adenomas in spain

      ea0099rc5.8
  • Rapid Communications 6: Thyroid | Part I
  • • Age-specific reference intervals for TSH and FT4 to optimize diagnosis of thyroid disease

      ea0099rc6.1
    • Interpretation of TPOAb measurement in pregnancy: An individual participant data meta-analysis

      ea0099rc6.2
    • Maternal thyroglobulin and thyroid function during pregnancy and offspring neurodevelopment

      ea0099rc6.3
    • Local treatment improves outcome of RAI - Refractory differentiated thyroid carcinoma (DTC) patients irrespectively of tyrosine kinase inhibitors (TKI) treatment: a single center experience

      ea0099rc6.4
    • Unusual manifestation of thyroid hormone receptor sz resistance

      ea0099rc6.5
  • Rapid Communications 7: Endocrine-related Cancer
  • • PRAP study - Partial versus radical adrenalectomy for hereditary pheochromocytomas

      ea0099rc7.1
    • The presence of abortive changes in thyroid tumors serves as a strong indicator of underlying DICER1 mutations

      ea0099rc7.2
    • Activating the intratumoral IFN[gamma]R-pathway in adrenocortical carcinoma potently enhances antitumor functionality of CAR-T cells by modulating immune cell adhesion and responsiveness

      ea0099rc7.3
    • Decrease in anticortisolic drmg osilodrostat plasma exposure in patients treated with mitotane for adrenocortical carcinoma

      ea0099rc7.4
    • Fibroblast-mediated modulation of GI-NETs: Implications for drmg response and tumor invasion

      ea0099rc7.5
    • The expression and prognostic value of somatostatin and glucagon-like peptide 1 receptors in insulinoma

      ea0099rc7.6
  • Rapid Communications 8: Thyroid | Part II
  • • The role of preexisting diabetes mellitus on the risk for aggressive thyroid cancers

      ea0099rc8.1
    • Somatic RAS mutations in thyroid nodules: possible protective effect?

      ea0099rc8.2
    • Thyroid sequencing: What the cell am i using here?

      ea0099rc8.3
    • The increased FCRL mRNA expression in patients with Graves' disease is associated with hyperthyroidism (but not with positive thyroid antibodies)

      ea0099rc8.4
    • Color Doppler ultrasound and real-time elastography in patients with hypothyroidism for the prediction of levothyroxine replacement: A cross-sectional study of 338 patients

      ea0099rc8.5
  • Rapid Communications 9: Pituitary and Neuroendocrinology | Part II
  • • Assessment of cardiovascular risk and coronary calcium deposits in women with hypopituitarism

      ea0099rc9.1
    • Elevated prolactin: Do not over investigate, cannulate!

      ea0099rc9.2
    • Identifying potential small molecule [ldquo]metabolites[rdquo] as biomarkers for growth hormone deficiency (GHD): Insights from a novel mouse model

      ea0099rc9.3
    • The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells

      ea0099rc9.4
    • Pregnancy and acromegaly: Clinical outcomes of retrospectively analysed data from the German Acromegaly Registry

      ea0099rc9.5
    • Prevalence and determinants of microvascular and macrovascular complications of diabetes in acromegaly patients: A prospective case-control cross-sectional study

      ea0099rc9.6
    • Pituitary apoplexy: A retrospective canadian single center cohort study

      ea0099rc9.7
  • Rapid Communications 10: Calcium and Bone | Part II
  • • First-line F18-choline PET/CT Versus Tc99m-sestaMIBI SPECT/CT in the surgical management of primary hyperparathyroidism: a diagnostic randomized phase III trial

      ea0099rc10.1
    • Clinical features of a multicenter Italian cohort of adult patients with X-linked hypophosphatemia

      ea0099rc10.2
    • Autosomal dominant hypocalcemia type 1 (ADH1): Experience from an Italian center

      ea0099rc10.3
    • Increased bone fragility over time in women with chronic hypoparathyroidism: Real-world data from the HypoparaNet Italian Cohort

      ea0099rc10.4
    • Determinants of vertebral fractures and effectiveness of anti-resorptive drmgs in pre-menopausal women with early breast cancer under hormone deprivation therapies: A multicenter real-world study

      ea0099rc10.5
  • Rapid Communications 11: Adrenal and Cardiovascular Endocrinology | Part II
  • • Changing clinical presentation of pheochromocytomas in a tertiary centre

      ea0099rc11.1
    • Contralateral suppression in adrenal venous sampling predicts clinical and biochemical outcome in primary aldosteronism

      ea0099rc11.2
    • Light chromatography and mass spectrometry proteomic analysis of formalin fixed tissue of Bilateral Macronodular Adrenocortical Disease (BMAD) reveals various class correlating with molecular groups

      ea0099rc11.3
    • Urine steroid metabolomics to diagnose endocrine hypertension: results from the ENS@T-HT project

      ea0099rc11.4
    • Assessment of adrenal function after prednisolone treatment in patients with polymyalgia rheumatica and/or giant cell arteritis - Data from the double edge-replace study

      ea0099rc11.5
    • Modulation of calcium signaling on demand to decipher the molecular mechanisms of primary aldosteronism

      ea0099rc11.6
    • An artificial intelligence-based decision support system for classifying patients with adrenal tumors

      ea0099rc11.7
  • Rapid Communications 12: Diabetes, Obesity, Metabolism and Nutrition | Part II
  • • Effects of semaglutide, Peptide YY3-36 and empagliflozin on metabolic dysfunction associated fatty steatotic liver disease in diet-induced obese rats with chronic nitric oxide synthase-inhibition

      ea0099rc12.1
    • Predictors of poor response to semaglutide for weight management

      ea0099rc12.2
    • Adipose tissue analysis toolkit (ATAT) for automated analysis of adipocyte size and extracellular matrix in white adipose tissue

      ea0099rc12.3
    • Hypoglycaemia following the 2-hour 75g OGTT in pregnancy - investigating maternal and foetal outcomes

      ea0099rc12.4
    • Effects of antagonists of the NPY-2 receptor, semaglutide, PYY3-36, and empagliflozin on metabolic dysfunction-associated steatotic liver disease in diet-induced obese rats

      ea0099rc12.5
  • Rapid Communications 13: Late Breaking
  • • MTHFR 677 TT and CT genotype related epigenetic changes and hyperhomocysteinemia in Hypothyroidism and its management, a family case report

      ea0099rc13.1
    • Comprehensive genetic analyses of sporadic and seemingly idiopathic hypoparathyroidism by whole-exome sequencing: Identification of novel GCM2 and AIRE mutations

      ea0099rc13.2
    • Comparison of metyrapone, osilodrostat and ketoconazole in the therapy of endogenous Cushing's syndrome: The MOSKETEER study

      ea0099rc13.3
    • Development and validation of an LC-MS/MS method to measure 7-alpha-hydroxy-4-cholesten-3-one (C4) for the assessment of bile acid dysregulation in PCOS

      ea0099rc13.4
    • Dose response relationship between Denosumab treatment and germ cell proliferation of humanized RANKL mice in vivo and in testicular tissue cultures

      ea0099rc13.5
    • The clinical profile of silent and subclinical somatotroph PitNETs according to the immunohistochemical staining

      ea0099rc13.6
• Poster Presentations
• • Adrenal and Cardiovascular Endocrinology
  • • Reversal of cardiac damage after treatment for aldosterone-producing adenoma and idiopathic hyperaldosteronism - A Prospective Cardiac Magnetic Resonance Imaging study

      ea0099p1
    • Prospective, multi-country, observational study of patients with endogenous Cushing's syndrome exposed to Ketoconazole (using the existing European Registry on Cushing's Syndrome (ERCUSYN)), to assess drug use, safety and effectiveness

      ea0099p2
    • Fingerprints of increased susceptibility to adrenal crisis in patients with chronic adrenal insufficiency

      ea0099p3
    • The truth hidden behind a case of resistant hypertension

      ea0099p4
    • A case of a composite pheochromocytoma with a spindle cell sarcoma exhibiting aggressive behavior

      ea0099p5
    • The differential impact of oral classic and 11-oxygenated androgen precursor administration on downstream androgen metabolism and insulin sensitivity in women with polycystic ovary syndrome

      ea0099p6
    • Inflammation-based scores in a large monocentric cohort of adrenocortical carcinoma and adrenocortical adenoma: role of the hormonal secretion pattern

      ea0099p7
    • Enhanced well-being in patients with congenital adrenal hyperplasia on modified-release hydrocortisone compared to conventional glucocorticoid replacement

      ea0099p8
    • Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas

      ea0099p9
    • Nausea and vomiting, a clue for the diagnosis of pheochromocytoma?

      ea0099p10
    • A rare case of testicular adrenal rest tumor associated to X-linked adrenoleukodystrophy

      ea0099p11
    • How to assess adrenal function during low dose prednisolone treatment - impact of a 1- vs 2-day prednisolone pause before the ACTH test: Results from the Double Edge-Rescue Study

      ea0099p12
    • Morning cortisol levels in patients with established primary adrenal insufficiency

      ea0099p13
    • Improved selectivity of adrenal venous sampling with the use of alternative steroids to cortisol

      ea0099p14
    • Dysregulation of salivary cortisol rhythm in non-secreting and mild cortisol-secreting adrenal incidentalomas

      ea0099p15
    • False-positive and false-negative results during screening, confirmatory testing and subtyping for suspected primary aldosteronism: lessons from Prosaldo

      ea0099p16
    • Plasma catestatin and relaxin-2 levels may predict impaired glucose metabolism in patients with primary hypertension

      ea0099p17
    • Clinical, biochemical, histopathological, and metabolic characteristics of patients with pheochromocytomas

      ea0099p18
    • Intra-tissular profile of adrenal steroids reveals variable levels associated with adrenocortical tumors (ACT) differentiation and suggests alterations in steroids export

      ea0099p19
    • Study on the pathogenesis of adrenocortical adenoma with bilateral independent secretion of aldosterone and cortisol: a case report and literature review

      ea0099p20
    • Analysis of salivary dexamethasone does not improve the specificity of the dexamethasone suppression test

      ea0099p21
    • Update on autoimmune polyendocrine syndrome type-1 in Norway: Using longitudinal immune cell composition incorporated with clinical features

      ea0099p22
    • Using basal cortisol cut-off to define adrenal sufficiency in a Southeast Asian population

      ea0099p23
    • Adrenocortical cells are prone to regulated cell death during in vitro septic conditions

      ea0099p24
    • Prevalence and outcome of primary aldosteronism in PBMAH: A single center study and systematic review of the literature

      ea0099p25
    • Towards precision medicine in adrenocortical carcinoma; predicting response to mitotane using proteomics

      ea0099p26
    • Impact on immunophenotype of switching from conventional glucocorticoids to modified-release hydrocortisone in congenital adrenal hyperplasia

      ea0099p27
    • Insulin tolerance test for the diagnosis of adrenal insufficiency

      ea0099p28
    • Pheochromocytoma-induced pseudo-Cushing syndrome

      ea0099p29
    • An unexpected Adrenal Lymphangioma: A case report

      ea0099p30
    • Blood pressure changes during smoking cessation on dulaglutide and placebo treatment - a secondary analysis of the randomized, double-blind, placebo-controlled SKIP trial

      ea0099p31
    • Physical activity after planned cessation of prednisolone treatment in patients with polymyalgia rheumatica and/or giant cell arteritis: baseline data from the double edge-replace study

      ea0099p32
    • Webinars for patient education on congenital adrenal hyperplasia

      ea0099p208
    • Impact of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1

      ea0099p214
    • Incidence of adrenal crisis in Congenital Adrenal Hyperplasia (CAH) patients during a prospective monitored long-term study of modified-release hydrocortisone (MRHC) capsules, (Efmody)

      ea0099p215
    • Psychotropic drugs in patients with Addison's disease: A Swedish population-based cohort study

      ea0099p216
    • Brown adipose tissue activation on 18FDG-PET/CT scan in phaeochromocytoma: A case series

      ea0099p217
    • Severe hyponatraemia and hyperkalaemia in pre-eclampsia due to hypoadrenalism/functional hypoadrenalism

      ea0099p218
    • 11[beta]-hydroxysteroid dehydrogenase type 1 inhibition unmasks multiple pathways that may mitigate the adverse effects of prescribed prednisolone

      ea0099p219
    • Adrenalectomy improves blood pressure and insulin secretion in adrenal incidentalomas and MACS

      ea0099p220
    • Constitutional duplication of PRKACA gene is a cause of isolated primary pigmented nodular adrenocortical disease (PPNAD)

      ea0099p221
    • Lysophosphatidylcholines and acylcarnitines: Novel markers of physiological glucocorticoid action in adipose tissue

      ea0099p222
    • Medication-associated false positive results for plasma normetanephrine, metanephrine and methoxytyramine

      ea0099p223
    • Comparison of antihypertensive effects between eplerenone and esaxerenone, mineralocorticoid receptor antagonists, in patients with primary aldosteronism

      ea0099p224
    • Baseline characteristics of children and adolescents with classic congenital adrenal hyperplasia enrolled in CAHtalyst pediatric, a phase 3 Study of Crinecerfont, a corticotropin-releasing factor type 1 receptor antagonist

      ea0099p225
    • Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma

      ea0099p226
    • CXCR4-directed [68Ga]Ga-PentixaFor PET/CT as a diagnostic modality in subtyping primary aldosteronism

      ea0099p227
    • Impact of glucocorticoid-induced adrenal insufficiency on health-related quality of life in patients receiving long-term low dose prednisolone treatment: Results from the double edge-rescue trial

      ea0099p228
    • Benefits and harms according to intensity of statin therapy in Korean patients with dyslipidemia

      ea0099p229
    • Description of recreational male and female athletes illicitly using androgenic anabolic steroids

      ea0099p230
    • 3D printed, personalized cortisol for cortisol deficiencies

      ea0099p231
    • Prevalence and treatment of osteoporosis and bone fractures in Cushing's syndrome across Europe

      ea0099p232
    • Decoding adrenal marginal zone lymphoma's silent narrative

      ea0099p233
    • Fine needle aspiration cytology of adrenal lesions: A 22-year single center experience

      ea0099p234
    • SIAH1, a regulator of the Wnt/[beta]-catenin pathway in human adrenocortical cells

      ea0099p235
    • Impact of environmental pollution on adrenocortical carcinoma in Italy

      ea0099p236
    • Fertility outcomes in women with classic and non-classic congenital adrenal hyperplasia on modified-release hydrocortisone (MR-HC)

      ea0099p237
    • Musculoskeletal health and body composition in patients discontinuing long-term prednisolone treatment - prospective data from the replace Study

      ea0099p238
    • Peripheral cortisol concentration during adrenal vein sampling for primary aldosteronism

      ea0099p239
    • Management of Giant Pheochromocytomas: A single tertiary center experience

      ea0099p240
    • Treatment outcomes in patients with recurrent adrenocortical carcinoma

      ea0099p241
    • Congenital adrenal hyperplasia and myelolipomas: A case report

      ea0099p242
    • Does 177Lu-DOTA-TATE works in metastatic cardiac paraganglioma?

      ea0099p243
    • Cardiovascular risk in patients with primary hyperparathyroidism

      ea0099p244
    • [beta]-estradiol contributes to sex differences in resilience to septic-induced cardiacdysfunction via GPER-1/PPAR[delta]/NLRP3 signaling

      ea0099p412
    • Glucocorticoid-induced adrenal insufficiency in patients with polymyalgia rheumatica and giant cell arteritis during long-term low-dose prednisolone treatment: Prediction based on indicators of exogenous hypercortisolism in the Double Edge Study

      ea0099p413
    • Aldosterone:metanephrine ratio better predicts laterality in patients with primary aldosteronism and mild autonomous cortisol co-secretion than aldosterone:cortisol ratio

      ea0099p414
    • Bilateral adrenal haemorrhage secondary to heparin induced thrombocytopenia- a rare cause and presentation of adrenal crisis

      ea0099p415
    • Increased cardiovascular risk in patients with germline VHL gene alterations - a UKBIOBANK-based genomic study

      ea0099p416
    • Germline targeted next-generation sequencing in patients with adrenal incidentalomas

      ea0099p417
    • Appraisal of modified tests for the diagnosis and treatment of primary aldosteronism: A single endocrine center experience

      ea0099p418
    • Primary aldosteronism: Small molecule antagonists of mutant KCNJ5 potassium channels

      ea0099p419
    • Different metabolic pathways associated with total cortisol exposure and the cortisol time profile: A randomized cross-over clinical trial

      ea0099p420
    • A case of reversible Brugada syndrome with severe hypothyroidism

      ea0099p421
    • Undertreated and undiagnosed adrenal insufficiency as a premature cause of death in glucocorticoid users

      ea0099p422
    • Baseline characteristics of adults with classic congenital adrenal hyperplasia enrolled in CAHtalyst, a phase 3 study of Crinecerfont, a corticotropin-releasing factor type 1 receptor antagonist

      ea0099p423
    • Diagnostic performance of dehydroepiandrosterone sulfate in predicting adrenal insufficiency

      ea0099p424
    • Income and work loss in patients with Addison's disease in Sweden: A nationwide population-based study

      ea0099p425
    • Evaluation of quality of life by AddiQoL-30 compared to SF-36 in patients with previous long-term prednisolone treatment

      ea0099p426
    • First report of inclisiran utilization for hypercholesterolemia treatment in real-world clinical settings in a middle east population

      ea0099p427
    • Development and validation of LC-MS/MS assay for simultaneous determination of thirteen steroid hormones and two synthetic steroids in saliva: potential utility for pediatric population and beyond

      ea0099p428
    • Establishing cut-off values for late-night salivary cortisol and cortisone measured by LC-MS/MS in the diagnosis of endogenous hypercortisolism

      ea0099p429
    • Holistic nursing care in acromegaly: A case report

      ea0099p430
    • Cognitive functions in patients with mild autonomous cortisol secretion: Is it related with the serum brain-derived neurotrophic factor level?

      ea0099p431
    • Role of ccfDNA-based biomarkers in classification of adrenocortical adenomas

      ea0099p432
    • Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronism

      ea0099p433
    • Even a nonfunctional adrenal incidentaloma carries a higher metabolic disease risk: Cross-sectional controlled study

      ea0099p434
    • Performance of plasma cortisol at 1600 hours for the diagnosis of Cushing syndrome

      ea0099p435
    • Different modes of cell death induced by chemotherapeutic agents in treatment resistant and sensitive models of adrenocortical carcinoma

      ea0099p436
    • Adrenocortical activity in patients with vasovagal syncope

      ea0099p437
    • A service review of phaeochromocytoma management at the regional adrenal referral centre

      ea0099p438
    • NFAT and risk of dementia

      ea0099p439
    • The challenges of adrenal incidentaloma evaluation in dialysis patients

      ea0099p440
    • Association between endothelial dysfunction and androgen levels in men with coronary artery disease

      ea0099p441
    • Premature Adrenarche and metabolic dysfunction - a systematic review and meta-analysis

      ea0099p442
  • Calcium and Bone
  • • Elevated serum uric acid in asymptomatic primary hyperparathyroidism: a biomarker of disease severity?

      ea0099p33
    • Extensive scalp calcification in pseudohypoparathyroidism type 1A: A case report and genetic insight

      ea0099p34
    • Utility of 18F-choline PET-CT in the localization of adenomas in primary hyperparathyroidism

      ea0099p35
    • Impact of parathyroidectomy on calcium metabolism, bone mineral density and trabecular bone score in patients with non-syndromic primary hyperparathyroidism

      ea0099p36
    • Intrathyroidal parathyroid adenoma: Two case reports

      ea0099p37
    • Hypoparathyroidism following thyroid surgery: Risk factors and the role of early postsurgical PTH determination

      ea0099p38
    • Co-morbidities in adults with hereditary hypophosphatemia compared to controls - a retrospective Danish register study

      ea0099p39
    • Comparative effects of vitamin D supplementation on serum calciotropic hormone profile, in orthodox nuns with hypovitaminosis d in different regions of greece, versus intermittent fasting and western diet in lay women

      ea0099p40
    • Frequency and causes of hypophosphatemia in internal medicine patients

      ea0099p41
    • Unveiling unique clinical phenotypes of hip fracture patients and the temporal association with cardiovascular events in Hong Kong and the United Kingdom: A retrospective study

      ea0099p42
    • The association between the 'time to first fracture' and imminent fracture risk - data from the FRISBEE cohort

      ea0099p43
    • Risk of sarcopenia can predict quality of life in Primary Hyperparathyroidism

      ea0099p44
    • Education, and early retirement in patients with hereditary hypophosphatemia compared to controls - a retrospective Danish register study

      ea0099p245
    • A rare cause of bone pain: Fibrodysplasia ossificans progressiva

      ea0099p246
    • More potent antiresorptive effect of denosumab versus zoledronate in osteoporotic postmenopausal women with primary hyperparathyroidism

      ea0099p247
    • Comparison of fractional excretion of calcium from different urine samples in the differentiation between primary hyperparathyroidism and familial hypocalciuric hypercalcemia

      ea0099p248
    • Burosumab treatment for FGF23-related hypophoshatemia in an adult patient with severe fibrous dysplasia in McCune-Albright syndrome

      ea0099p249
    • Cystic parathyroid adenomas - a rare case of primary hyperparathyroidism: Two case reports

      ea0099p250
    • Age-associated changes of fast-twitch skeletal muscle fibers in male rats

      ea0099p251
    • Role of variants of uncertain significance in determining bone fragility or low bone mineral density in adults: A multicenter study

      ea0099p252
    • Alterations in phosphate metabolism in patients with Klinefelter's syndrome

      ea0099p253
    • Hypocalcemia after hyperthyroidism surgical treatment: Besides iatrogenic hypoparathyroidism

      ea0099p254
    • Evaluating novel bone biomarkers (FGF2, lipocalin, sclerostin) in patients with tumor induced osteomalacia (TIO) and acromegaly

      ea0099p255
    • The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies

      ea0099p256
    • 22q11.2 deletion syndrome diagnosed in the context of seizure and hypocalcemia in adulthood

      ea0099p443
    • Hyperostosis frontalis interna - a case of Morgagni-Stewart-Morel syndrome

      ea0099p444
    • Clinical characterization of a cohort of patients with multiple endocrine neoplasia syndrome type 1 (MEN1): role of the MEN1 gene mutation on the phenotypic expression of the syndrome

      ea0099p445
    • Investigating the etiology of non-surgical hypoparathyroidism: insights from a sponsored genetic testing program

      ea0099p446
    • Optimal strategies for vitamin D supplementation in the management of severe vitamin D deficiency

      ea0099p447
    • Formation of new bone lesions in an adult patient with fibrous dysplasia/McCune-Albright syndrome over 19 years and the effect of postoperative hypoparathyroidism on bone turnover markers - case report

      ea0099p448
    • The incidence of fractures in cancer patients initiating immune check-point inhibitors

      ea0099p449
    • A pharmacoeconomic analysis from Italian guidelines for the management of sporadic primary hyperparathyroidism

      ea0099p450
    • Bone responsiveness in PTH resistance syndromes: preliminary data of a single centre retrospective study

      ea0099p451
    • Clustering of clinical and biochemical data for defining primary hyperparathyroidism 'phenotypes' and predicting parathyroid imaging results

      ea0099p452
    • Mild hyponatremia is not associated with degradation of trabecular bone microarchitecture despite bone mass loss

      ea0099p453
    • The clinical presentation of primary hyperparathyroidism: effects of obesity and vitamin D deficiency

      ea0099p454
  • Diabetes, Obesity, Metabolism and Nutrition
  • • The impact of diabetes mellitus on morbidity and mortality in patients with covid-19 pneumonia. retrospective study

      ea0099p45
    • Obesity in women with polycystic ovary syndrome -an individual participant data meta-analysis of well characterised, unselected populations

      ea0099p46
    • Demographics and baseline characteristics of patients with charcot foot: a multi-center cohort analysis

      ea0099p47
    • Screening for gestational diabetes in the first trimester: the impact of fasting blood glucose in maternal and foetal health

      ea0099p48
    • Overweight and obesity in survivors of childhood cancer

      ea0099p49
    • Post-lifestyle modification program changes in betatrophin and FGF21 levels among arab adolescents with varying levels of adiposity

      ea0099p50
    • A single nucleotide polymorphism in the EGF gene is associated with glycemic control in type two diabetes mellitus patients

      ea0099p51
    • First trimester fasting glycaemia ≥ 92 mg/dl and risk of gestational diabetes in the 24-28th week ogtt

      ea0099p52
    • Impact of gestational diabetes and its management on the nutritional balance and quality of life of a population of tunisian women

      ea0099p53
    • Diabetes and covid-19: factors involved in the occurrence of complications and death: about 60 cases

      ea0099p54
    • Adult sitosterolemia in singapore: a case report

      ea0099p55
    • Strength-endurance training and liraglutide treatment: impact on metabolic parameters in middle-aged ovariectomized female rats

      ea0099p56
    • The association of metabolic dysfunction-associated steatotic liver disease (masld) and metabolic syndrome with cardiovascular outcomes: a nationwide study

      ea0099p57
    • Biometric and metabolic changes at one-year follow-up in patients with obesity and steatotic liver disease undergoing endoscopic sleeve gastroplasty-endosleeve (apollo method)

      ea0099p58
    • Cardiac changes in obese patients following bariatric surgery

      ea0099p59
    • Predicting liver fibrosis using artificial intelligence in obese patiens

      ea0099p60
    • Evaluation of the digital support tool gro health W8Buddy as part of tier 3 weight management service

      ea0099p61
    • Advanced hybrid closed-loop therapy in adults with type 1 diabetes: outcomes in a real-world setting

      ea0099p62
    • Association of MMP-2 gene polymorphisms with diabetic retinopathy in tunisian population

      ea0099p63
    • Metabolic and cardio-renal benefits of SGLT2- inhibitors in diabetic patients

      ea0099p64
    • The effect of dynamics in fasting glucose level on the risk of chronic kidney disease and ESRD: a nationwide cohort study

      ea0099p65
    • Is type 1 diabetes a risk factor for insulin resistance in young adults?

      ea0099p66
    • Prevalence and predictive factors of sleep apnoea in type 2 diabetic patients

      ea0099p67
    • Analysis of autoimmunity to the insulin-receptor in diabetes mellitus

      ea0099p68
    • The correlation between heart failure and diabetic kidney disease in individuals diagnosed with type 2 diabetes mellitus

      ea0099p69
    • The sodium plunge: a world-record dip with a happy ending

      ea0099p70
    • Causal associations between adiposity markers and nuclear magnetic resonance spectroscopy-measured lipids in plasma: a mendelian randomisation study in 110,000 mexican adults

      ea0099p71
    • Metabolic and renal benefits of using sodium-glucose cotransporter type 2 inhibitors in patients with type 1 diabetes mellitus and continuous subcutaneous insulin infusion

      ea0099p72
    • Vitamin b12 deficit mimics diabetic polyneuropathy in patients taking metformin

      ea0099p73
    • Gestational diabetes: what is the evolution in the postpartum period, those on a hygienic diet, versus on insulin therapy?

      ea0099p74
    • Effect of alcohol-induced hypoglycemia on myocardial perfusion

      ea0099p75
    • Association between low vitamin d level and depressive symptoms

      ea0099p76
    • The prognostic significance of antinuclear antibodies in metabolic steatopathy: a cross-sectional study

      ea0099p77
    • Testosterone replacement therapy improves metabolic parameters in obese men with testosterone deficiency: a meta-analysis and systematic review

      ea0099p78
    • Serum Oxytocin predicts body dysmorphic concerns and ketosis occurrence in patients withobesity on a VLCKD

      ea0099p79
    • Resting metabolic rate in children with obesity: a predictor of metabolic syndrome

      ea0099p80
    • Sleep quality in adults with type 2 diabetes mellitus: a tunisian study

      ea0099p81
    • Maaori and pacific-specific diabetes protective crebrf r457q variant alters glucocorticoid receptor activity

      ea0099p82
    • Expression of pro-inflammatory cytokines and fibrinogen in human diabetic nephropathy

      ea0099p83
    • Cognitive disorders in elderly with type 2 diabetes

      ea0099p84
    • Mauriac syndrome in adolescents: A clinical entity that still exists

      ea0099p85
    • Testosterone levels in men with type 2 diabetes: impact of statins and dyslipidemia

      ea0099p86
    • Investigation of anti-diabetic effects of various extracts of Jatropha tanjorensis in BRIN-BD11 clonal pancreatic beta cells

      ea0099p87
    • NGO project on status report on pediatric diabetes in developing countries

      ea0099p212
    • Real-world comparison of real-time continuous glucose monitoring and intermittently scanned continuous glucose monitoring in glycemic control among individuals with type 1 diabetes: a nationwide cohort study

      ea0099p257
    • Unraveling the role of the upper small intestine microbiome in metabolic diseases: insight on new potential therapeutic interventions

      ea0099p258
    • The development of cardiovascular disease or cancer is correlated with higher FIB-4 in patients with T2DM

      ea0099p259
    • The influence of finerenone on renal function in patients with type 2 diabetes

      ea0099p260
    • Familial partial lipodystrophy:genetic and clinical data from a greek referral center

      ea0099p261
    • Exploring the metabolic and cellular/molecular benefits of mediterranean and a low-fat diet in the revertion of obesity and diabetes in mice

      ea0099p262
    • Risk of type 2 diabetes in 99,892 nordic women with polycystic ovary syndrome and 446,055 controls: national cohort study from Denmark, Finland and Sweden

      ea0099p263
    • Comparison of metabolic and immunological profile of 2 types of familial partial lipodystrophy syndromes (PLIN1 and LMNA)

      ea0099p264
    • Clinical outcomes of patients with diabetic foot ulcer treated with dalbavancin in the outpatient setting

      ea0099p265
    • MAFLD and type 2 diabetes: is dual therapy an effective option?

      ea0099p266
    • Acquired partial lipodystrophy: leptin and glucose blood levels in a pregnant patient

      ea0099p267
    • GLP-1RAs boost erectile function in men with type 2 diabetes and erectile dysfunction: results from a 1-year retrospective cohort study

      ea0099p268
    • Study of genetic predisposition and other pathogenetic mechanisms underlying hypogonadotropic hypogonadism in type 2 diabetes mellitus

      ea0099p269
    • Comparison between most recent guidelines about NAFLD medical treatment

      ea0099p270
    • Obesity in transition towards diabesity: anthropometric determinants and markers of tissue damage

      ea0099p271
    • TYG Index: a practical tool for evaluating metabolic parameters in obese individuals

      ea0099p272
    • Diagnostic accuracy of FIB-4 score compared to Fibroscan assessment of liver fibrosis in overweight and obesity patients

      ea0099p273
    • Impact of diabetes mellitus type 2 on the prognosis of metabolic steatopathy

      ea0099p274
    • Trajectories and associations of symptoms of mental health and well-being with insulin resistance and metabolic health in women with gestational diabetes

      ea0099p275
    • Cell cycle synchronization enhances insulin secretion in MIN6 cells

      ea0099p276
    • Evaluation of a new prototype ELISA for the detection of autoantibodies against IA2 in patients with type 1 diabetes mellitus

      ea0099p277
    • Use of glycated albumin in transfusion-dependent [beta]-thalassemic (TDT) patients with diabetes mellitus: preliminary results

      ea0099p278
    • Extracts of Vernonia amygdalina stimulated non-toxic insulin secretion from clonal pancreatic cells and improved glucose tolerance in mice with diet-induced obesity-diabetes

      ea0099p279
    • New onset diabetes after transplantation (NODAT) in kidney transplant recipient in Montenegro

      ea0099p280
    • Degenerative complications of diabetes type 2

      ea0099p281
    • Rare case of hypoglycemia attributed to sildenafil in a patient with primary pulmonary hypertension

      ea0099p282
    • Hepatic steatosis index as a non-invasive marker for liver steatosis in patients with endogenous cushing syndrome, Ercusyn krakow database

      ea0099p283
    • Analysis of the use of integrated continuous subcutaneous insulin infusion systems in pregnant women with type 1 diabetes

      ea0099p284
    • A cost-effectiveness analysis of inpatient continuous glucose monitoring vs capillary blood glucose

      ea0099p285
    • The clock regulator bmal1 mediates the circadian control of gc-dependent skeletal muscle catabolism by driving PI3K (P100[alpha])-GR interaction

      ea0099p286
    • Performance of a machine learning-based early warning system in hospitalized patients with diabetes mellitus

      ea0099p287
    • Asprosin- novel player in metabolic disorders

      ea0099p288
    • Exploring the nexus of sex hormones and obesity in adult males: insights from a comprehensive clinical analysis

      ea0099p289
    • The discourse of medical treatment for obesity: sentiment analysis of the literature

      ea0099p290
    • Endoscopic argon plasma coagulation (APC) treatment for dumping syndrome and post-bariatric hypoglucemia in patients with ROUX-EN-Y gastric bypass

      ea0099p291
    • The effect of ketogenic diet versus mediterranean diet on clinical and biochemical markers of inflammation in patients with obesity and psoriatic arthritis

      ea0099p292
    • Effectiveness of treatment with Vitamins B12 and D in patients with diabetic peripheral neuropathy by sudoscan

      ea0099p293
    • The relationship between emotion regulation strategies, illness uncertainty and health-promoting self-care in individuals with type-2 diabetes mellitus

      ea0099p294
    • Eating disorders in obese patients with type 2 diabetes

      ea0099p295
    • Unveiling connections: type 2 diabetes, male hypogonadism, and inflammation -insights from a clinical study

      ea0099p296
    • An hepatomegaly in a child with type 1 diabetes and celiac disease: what could it be?

      ea0099p297
    • Current prevalence and patterns of hypolipidemic medication based on real-life nation-wide data on 10, 816, 286 individuals

      ea0099p298
    • Effectiveness of dapagliflozin and sitagliptin fixed dose combination in indian patients with type 2 diabetes mellitus in real world settings: age stratified-analysis from a retrospective study

      ea0099p299
    • Effect of prior GLP-1 RA treatment on clinical outcomes in patients with type 2 diabetes initiating treatment with tirzepatide

      ea0099p455
    • Ghrelin system as a novel source of biomarkers and therapeutic tools in metabolic liver diseases

      ea0099p456
    • Characteristics of presentation and management of people with hypoglycaemia while on continuous glucose monitoring devices - pilot data from DEKODE hypoglycaemia study

      ea0099p457
    • Acute complications in diabetic patients during the month of ramadan: about 48 cases

      ea0099p458
    • Preoperative vitamin b1 levels are associated with reaching normal body mass index 1 year after bariatric surgery

      ea0099p459
    • Polycystic ovary syndrome in type 1 diabetes mellitus: a cross-sectional study of 785 women with diabetes and 1152 controls

      ea0099p460
    • Prognostics factors for regression from prediabetes to normoglycaemia: individual participant data meta-analysis

      ea0099p461
    • Glycemic control in patients with prediabetes acutely improves serum nlrp3 inflammasome and associated interleukins post-lifestyle modification

      ea0099p462
    • Relationship between the levels of asprosin, interleukin-6 and adiponectin in patients with type 2 diabetes mellitus with or without chronic pancreatitis

      ea0099p463
    • Combined dulaglutide-dapagliflozin treatment improves vascular dysfunction and albuminuria vs DPP4 inhibitors independently of glycaemic control

      ea0099p464
    • PDE4 inhibition attenuates non-alcoholic fatty liver disease by increasing vldl secretion in obese animals

      ea0099p465
    • Impact of simulation via instant messaging -birmingham advance (SIMBA) on clinician's confidence to manage type 1 diabetes mellitus using technological advances in endocrinology

      ea0099p466
    • Transcriptome of periadrenal and subcutaneous fat in patients with hyperaldosteronism in comparison to patients with non-functional adenomas

      ea0099p467
    • Weaning timing impact on adipose tissue remodelling in mice

      ea0099p468
    • Implication of metabolically healthy obesity on the risk of incident pancreatic cancer: a nationwide population-based cohort study

      ea0099p469
    • Visceral fat lipolysis using high-dose multichannel non-ablative energy-based device: anthropometric, biochemical and imaging mri study

      ea0099p470
    • Subgroup analysis of phase 3 study of fixed-dose combination of dapagliflozin, glimepiride and metformin IR in type 2 diabetes mellitus patients with HbA1c 9%-11%

      ea0099p471
    • How does neuropathic pain affect sleep quality in adults with type 2 diabetes ?

      ea0099p472
    • The association between serum cholecalciferol level and lipid profile in patients with latent autoimmune diabetes in adults

      ea0099p473
    • Relation of diabetic peripheral neuropathy and vitamin d deficiency

      ea0099p474
    • Ultrasound diagnosis of diabetic nephropathy

      ea0099p475
    • Risk factors and surgical outcomes of diabetic foot in patients with diabetes at larribere clinic in oran university hospital

      ea0099p476
    • Mitochondrial diabetes and m.3243A> G mutation in MTL1 gene: MIDD/MELAS syndrome

      ea0099p477
    • Advanced glycation endproducts (AGE) and severity of diabetic retinopathy association analysis in latvia

      ea0099p478
    • "Glycemic control and hypogonadism in men with type 2 diabetes: cross-sectional study"

      ea0099p479
    • Tolvaptan fortnightly can reduce hyponatraemia related inpatient admissions

      ea0099p480
    • Effect of L-arginine and agmatine on GLP-1 and PYY secretion in human NCI-H716 cells: the role of calcium sensing receptors

      ea0099p481
    • The conjugation of tigerinin-1r with modified gastric inhibitory polypeptide enhanced its cellular uptake and metabolic actions

      ea0099p482
    • Etiological profile and evolution of secondary diabetes due to endocrinopathies

      ea0099p483
    • Beta-type estradiol receptor modulates hepatocyte responses to metabolic challenges

      ea0099p484
    • Diabetes mellitus in patients undergoing pancreatectomy (T3cDM): preliminary data analysis

      ea0099p485
    • The waist-to-height ratio represents better than body mass index the prognostic impact of obesity on metabolic steatopathy

      ea0099p486
    • Blood glucose and insulin level during oral glucose tolerance test as predictors for treatment efficacy in obese patients

      ea0099p487
    • Metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a major role for transient elastography in the screening of significant liver fibrosis

      ea0099p488
    • Diabetes remission after bariatric surgery: a 10-years follow-up study

      ea0099p489
    • Body mass index is a better predictor than waist circumference to assess the risk of advanced hepatofibrosis

      ea0099p490
    • Diabetes and severe obstructive sleep apnea syndrome: effect on right ventricle systolic function

      ea0099p491
    • The dependence of anxiety and depression indicators on serum cholecalciferol level in patients with latent autoimmune diabetes in adults

      ea0099p492
    • Sleep apnoea and degenerative complications in type 2 diabetes

      ea0099p493
    • Diabetic ketoacidosis - severe case, in a type 1 diabetes patient, with chronic diarrhea and mental disorders -case report

      ea0099p494
    • Comparative analysis of economic burden between cardiovascular and renal complications in hospitalized tunisian patients with type 2 diabetes: a retrospective study

      ea0099p495
    • Assessment of overactive bladder syndrome symptoms (OABSS) score following the start of sodium-glucose co-transporter-2 inhibitors in individuals with type-2 diabetes mellitus

      ea0099p496
    • Western-style diet in the presence of elevated circulating testosterone induces adipocyte hypertrophy and t-cell dysfunction in rhesus macaques

      ea0099p497
  • Endocrine-Related Cancer
  • • The BRAF K601E mutation in thyroid tumors: One alteration with a dual clinical significance

      ea0099p88
    • Effectiveness of temozolomide treatment in SDHx mutant and wildtype metastatic pheochromocytoma and paraganglioma - results of a European restrospective multicentre study

      ea0099p89
    • Does mitotane offer lasting cure or transitory benefits following adrenocortical carcinoma surgery?

      ea0099p90
    • Clinical impact and genetic alterations in the DAXX gene in patients with neuroendocrine tumors of the gastroenteropancreatic system and the lung

      ea0099p91
    • How well does 'real world' management of Immune check point inhibitor induced hypophysits (ICI-Hp) reflect the European Society of Endocrinology (ESE) 2023 clinical practice guidelines (CPG)?: Experience from a single tertiary care centre

      ea0099p92
    • Risk of differentiated thyroid cancer among Danish women with polycystic ovary syndrome

      ea0099p93
    • Cervico-mediastinal hematoma: Atypical presentation of parathyroid carcinoma associated to hashimoto thyroiditis

      ea0099p94
    • Do immune checkpoint inhibitor-related endocrinopathies affect survival rates in cancer patients? Presentation of two case reports

      ea0099p95
    • Increased calcitonin level in cases with multinodular goitre and ectopic Cushing syndrome - diagnostic challenges

      ea0099p96
    • Spontaneous and treatment-related changes in calcitonin doubling rate of medullary thyroid cancer. Long-term experience in a patient with multiple endocrine neoplasia type 2B

      ea0099p97
    • Targeting focal adhesion kinase (FAK) and spleen tyrosine kinase (SYK) in gastrointestinal neuroendocrine tumors: Unveiling mechanisms and anti-proliferative effects

      ea0099p98
    • Metastatic paragangliomas - real world data in a single tertiary center

      ea0099p99
    • Incidentaloma on Ga-68-DOTANOC PET; prevalence and clinical significance

      ea0099p100
    • Comparison of existing guidelines on the perceived endocrine symptoms of breast cancer patients - preliminary results

      ea0099p209
    • The lived experience of people with adrenocortical carcinoma

      ea0099p210
    • Endocrine autoimmunity during immunotherapy for cancer - a snapshot from an Oncologic Institute in Romania

      ea0099p213
    • An apparently non-functional retroperitoneal SDHB-related paraganglioma

      ea0099p300
    • Dual targeting Boolean logic gate CAR-T cells for selective tumor antigen encounter exert potent antitumor efficacy in advanced adrenocortical carcinoma

      ea0099p301
    • Alteration in the molecular components of machinery that regulate gene expression mechanisms and genomic stability in thyroid cancer and their association with tumour behaviour and/or clinical features

      ea0099p302
    • Clinical characteristics and survival of patients with functional pancreatic neuroendocrine tumors

      ea0099p303
    • Basal calcitonin and calcium gluconate test in suspect medullary thyroid carcinoma: Are we expecting too much from stimulated calcitonin?

      ea0099p304
    • Cell cycle regulation in parathyroid adenomas and multiglandular parathyroid disease: Similarities, differences and heterogeneity

      ea0099p305
    • Long-acting starch (Glycosade(R)): An effective treatment for insulinoma-induced hypoglycemia - A case report

      ea0099p306
    • The intrinsically disordered activation function 1 of Progesterone receptor is involved in the dynamics of the receptor complex

      ea0099p307
    • Possible prognostic role of BMI before chemotherapy in the outcomes of women with ovarian cancer

      ea0099p308
    • Cystic mediastinal lesions as presenting manifestation of papillary thyroid cancer

      ea0099p309
    • Immunohistochemical profiling of HIF-2[alpha] and SSTR2 with the tumor microenvironment in metastatic pheochromocytoma and paraganglioma

      ea0099p310
    • The impact of primary tumor site on clinical manifestation and prognosis of ectopic Cushing's syndrome (ECS). Do pulmonary neuroendocrine tumors stand out?

      ea0099p311
    • Once-daily oral paltusotine in the treatment of patients with carcinoid syndrome: interim results from a phase 2, randomized, parallel-group study

      ea0099p498
    • Early detection of recurrence and progress using serum steroid profiling by LC-MS/MS in patients with adrenocortical carcinoma

      ea0099p499
    • Catching the silent culprits: Prospective TERT promoter mutation screening for minimally invasive follicular and oncocytic thyroid carcinoma in clinical practice

      ea0099p500
    • Clinical features and outcome in patients with functional head and neck paragangliomas: French national cohort and literature review

      ea0099p501
    • Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients

      ea0099p502
    • Presurgical lactate dehydrogenase (LDH) levels: A risk factor for disease progression in operated adrenocortical carcinomas

      ea0099p503
    • Advanced ACC stage: Therapeutic approach and biological findings

      ea0099p504
    • Growth differentiation factor 15 (GDF-15) is induced by mitotane in adrenocortical carcinoma and associated with poor prognosis and impaired responsiveness to immunotherapy

      ea0099p505
    • Primary hyperparathyroidism due to parathyroid cancer or atypical adenoma. a third-level spanish hospital experience

      ea0099p506
    • SRSF6 modulates histone-chaperone HIRA splicing to orchestrate androgen and E2F signalling in prostate cancer

      ea0099p507
    • Adrenal tumors in children and adolescents in Sweden: A diagnosis related groups-based analysis from 2005-2019

      ea0099p508
    • Variants of genes that reduce the function of the progesterone receptor, vitamin D receptor, and 1[alpha]-hydroxylase enzyme are associated with an earlier onset of breast cancer

      ea0099p509
  • Environmental Endocrinology
  • • Systematic review of thyroid hormone patterns observed after exposure to endocrine disruptors in humans

      ea0099p201
    • Urinary iodine concentration and markers of thyroid activity in pregnant faroese women

      ea0099p202
    • Exploring a new avenue of disseminating peer-reviewed information on thyroid and PCOS conditions

      ea0099p203
    • The short-term effect of apparent temperature on the hydration marker plasma sodium

      ea0099p204
    • Real-life exposure to toxic metals: impact on thyroid gland function and male reproductive system in rats

      ea0099p205
    • The influence of environmental and behavioral factors on male infertility associated hormones

      ea0099p206
  • Pituitary and Neuroendocrinology
  • • Assessment of 24h ambulatory blood pressure in women with sheehan syndrome: prevalence of hypertension and disruption of the circadian blood pressure rhythm

      ea0099p101
    • Establishing BMI-Related thresholds for the 1 mg dexamethasone suppression test: a retrospective analysis

      ea0099p102
    • Prevalence of hypopituitarism in adults treated with intensity-modulated radiotherapy for primary, non-pituitary, brain tumours

      ea0099p103
    • Increment in KI-67 proliferation indices over time is associated with worse survival outcomes in small-intestinal neuroendocrine tumours

      ea0099p104
    • Infectious complications during cushing's disease: about 51 cases

      ea0099p105
    • Diagnostic value of a 3% hypertonic saline infusion test in differential diagnosis between adh deficiency and primary polydipsia

      ea0099p106
    • Circulating levels of mir-375 in cushing's disease patients and evaluation of its role in the regulation of sstr2 expression in murine pituitary corticotroph tumor cell model

      ea0099p107
    • Soluble [alpha]-klotho protein, nesfatin-1 and IGFBP-3 concentrations in the biochemical diagnosis and monitoring treatment effects in patients with acromegaly

      ea0099p108
    • Utilization of MRI in the work-up of mild hyperprolactinemia

      ea0099p109
    • Obesity in survivors of childhood-onset craniopharyngioma - impact of parental body mass index at craniopharyngioma diagnosis?

      ea0099p110
    • A randomised phase 3 trial to assess efficacy and safety of CAM2029, an octreotide subcutaneous depot, in patients with acromegaly

      ea0099p326
    • Metabolic syndrome in women with sheehan syndrome: prevalence and associated factors

      ea0099p112
    • 2-[18F]FDG PET imaging biomarkers for clinical and metabolic assessment in ectopic cushing syndrome. increased spleen FDG uptake as a helpful parameter to predict the presence of metastases - a pilot study

      ea0099p113
    • Obesity-Related pseudo-cushing syndrome and pituitary incidentaloma: a case study

      ea0099p114
    • The value of digital quantification of somatostatin receptor subtypes 2 and 5 immunostaining in GH-secreting pituitary tumors

      ea0099p115
    • Cell lineage specific differences in clinical behavior of clinically non-functioning pituitary adenomas according to the 2017 WHO classification - a systematic review and meta-analysis

      ea0099p116
    • Proton beam radiotherapy for treatment of functional pituitary adenomas

      ea0099p117
    • Hyponatremia after COVID-19 is frequent in the first year and increases re-admissions

      ea0099p118
    • Management of carcinoid heart disease in neuroendocrine tumor patients: a retrospective study

      ea0099p119
    • Approaching the reality of restoring GH secretion and growth with the investigative oral growth hormone secretagogue (GHS) LUM-201 in moderate pediatric growth hormone deficiency (PGHD)

      ea0099p120
    • Adipsic diabetes insipidus - a rare complication of craniopharyngiomas

      ea0099p121
    • Cushing's syndrome: normalization of cortisol is just the beginning

      ea0099p122
    • Longterm-outcomes in patients with cushing's disease vs non-functioning pituitary adenoma after pituitary surgery: an active-comparator cohort study

      ea0099p123
    • Neuropsychological profile in acromegaly: cross sectional analysis and preliminary prospective long-term study

      ea0099p124
    • Consensus and controversies on the diagnosis of GH-deficiency in children and adults - A Delphi survey by the GH research society

      ea0099p125
    • Replace: a randomized controlled trial on the effect of hydrocortisone or placebo in patients with reported symptoms of glucocorticoid-induced adrenal insufficiency after terminating prednisolone for polymyalgia rheumatic/giant cell arteritis

      ea0099p126
    • Gonadotroph pituitary tumors: not always nonfunctioning

      ea0099p127
    • Posterior pituitary tumours: a single institutional experience of 19 patients

      ea0099p128
    • Usefulness of salivary cortisol in the diagnosis of adrenal insufficiency and evaluation of the hypothalamic-pituitary-adrenal axis

      ea0099p129
    • Paradoxical responses to pasireotide in patient with cushing's disease

      ea0099p130
    • Comparative efficacy and safety of osilodrostat vs metyrapone for the treatment of Cushing's syndrome - a matching-adjusted indirect comparison using LINC-3 and LINC-4

      ea0099p131
    • Is urine s[alpha]kl a potential biomarker in acromegaly?

      ea0099p132
    • Exploring the cardiovascular effects of recombinant human growth hormone therapy: a prospective study on endothelin-1 and asymmetric dimethyl arginine in adults with growth hormone deficiency

      ea0099p133
    • Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?

      ea0099p134
    • Comprehensive clinical, transcriptomic, and functional relevance of the telomerase-shelterin system in pituitary tumors and craniopharyngiomas

      ea0099p135
    • Effect of oral urea on copeptin levels in healthy adults: a double-blind, randomized, placebo-controlled cross-over study

      ea0099p136
    • Anastrazole in the treatment of a cabergoline-resistant male prolactinoma

      ea0099p137
    • Challenges in the management of invasive macroprolactinomas: cranio-dural defect requiring surgery after cabergoline treatment

      ea0099p138
    • Pitfalls in diagnosis of the pituitary stalk lesion: infundibulo-neurohypophysitis or germ cell tumor?

      ea0099p139
    • Elimination of fall in glucose during glucagon stimulation test does not completely abolish an increase in growth hormone and cortisol concentrations

      ea0099p140
    • Maternal cortisol levels in pregnancy and intelligence quotient in children at 7 years of age. odense child cohort

      ea0099p312
    • TGFBR3L gene expression and relevance for the gonadotroph non-functioning pituitary neuroendocrine tumours

      ea0099p313
    • A complex clinical scenario: chiari type ii malformation coexisting with suprasellar paraganglioma and associated succinate dehydrogenase subunit b (SDHB) genetic mutation

      ea0099p314
    • Validation of baseline laboratory levels and a novel probability score in the diagnosis of patients with suspected arginine vasopressin deficiency (Central Diabetes Insipidus)

      ea0099p315
    • The pathogenic RET val804met variant in acromegaly: a new clinical phenotype?

      ea0099p316
    • Relevance of USP8 mutations in the pathogenesis of pituitary tumours of the corticotroph lineage

      ea0099p317
    • Circadian clock disruption impairs immune oscillation in chronic endogenous hypercortisolism: a multi-levels analysis from a multicenter clinical trial

      ea0099p318
    • Natural history of rathke's cleft cysts. a retrospective analysis of a fifteen centers experience in spain

      ea0099p319
    • Impact of clinical and treatment characteristics on HR-QoL in patients with prolactinoma - cross-sectional analysis of a dutch multicenter prospective cohort study

      ea0099p320
    • Apelin and copeptin levels in patients with chronic SIAD treated with empagliflozin - a secondary analysis of the SANDx trial

      ea0099p321
    • Minimum data set for global monitoring of the safety and efficacy of growth hormone replacement in adults - an expert group recommendation

      ea0099p322
    • Predictors of corticotroph tumour recurrence after surgical resection

      ea0099p323
    • Drug-induced hyperprolactinemia and granulomatous mastitis: a case report and literature review

      ea0099p324
    • Cyclic cushing's syndrome: a diagnostic challenge

      ea0099p325
    • Deciphering microenvironment interactions during age-related pituitary tumour onset and through orthotopic mouse pre-clinical model

      ea0099p111
    • High prevalence of vertebral fractures associated with age, GH, and bone mineral density in patients with acromegaly

      ea0099p327
    • Cytological, immunological and radiological predictors of the efficacy of first-generation somatostatin receptor ligands (fg-SRLs) in patients with acromegaly

      ea0099p328
    • Daytime sleepiness and health-related quality of life in patients with childhood-onset craniopharyngioma

      ea0099p329
    • A case of type 2 diabetes masked by insulinoma

      ea0099p330
    • Pituitary involvement in familial hemophagocytic lymphohistiocytosis type 5 associated with homozygous mutation in the syntaxin-binding protein-2 gene (STXBP2)

      ea0099p331
    • Sarcoma of the sphenoid sinus occurring 34 years after fractionated sellar 60Cobalt radiotherapy for acromegaly

      ea0099p332
    • Additive effect of combined treatment with the small peptide GH receptor antagonist, AZP-3813, and the somatostatin analog, octreotide, in decreasing IGF1 levels in the rat

      ea0099p333
    • Prognostic value of the pituitary apoplexy score for predicting hormonal and visual recovery of patients with pituitary apoplexy: results from a spanish multicentric study

      ea0099p334
    • Cardiovascular disease and gender differences in non-functioning pituitary tumors: preliminary data of a prospective study

      ea0099p335
    • Evaluation of new prognostic clinicopathological classification of pituitary adenomas proposed by trouillas et al. in patients with giant pituitary adenomas

      ea0099p336
    • Clinical and radiological predictive factors of dopamin agonist resistance in prolactinoma

      ea0099p337
    • Efficacy of pasireotide treatment in acromegaly: a systematic review and meta-analysis

      ea0099p338
    • T2-weighted MRI signal intensity of a somatotroph PitNETs-assessed with quantitative and qualitative methods- how our predictions are verified in the histopathological examination?

      ea0099p339
    • Improvements in diabetes and hypertension were sustained over long-term osilodrostat treatment in patients with Cushing's disease: A pooled analysis of LINC 3 and LINC 4

      ea0099p340
    • A case of meningitis mimicking pituitary macroadenoma

      ea0099p341
    • Is histological subtyping important in the prognostication of acromegaly?

      ea0099p342
    • Comparative analysis of giant and 'nearly giant' pituitary adenomas

      ea0099p343
    • Growth hormone potently stimulates fibroblast activation protein activity and collagen turnover - a prospective study in newly diagnosed patients with acromegaly before and after treatment

      ea0099p344
    • Expression pattern of select cell proliferation and apoptotic markers in non-functioning pituitary adenomas predictive of tumour growth/recurrence: a pilot project

      ea0099p345
    • Incidence of nephrogenic diabetes insipidus during prolonged sevoflurane sedation in the intensive care unit: a retrospective analysis and predictive model

      ea0099p346
    • Safety profile of growth hormone replacement (GHr) in GH deficient patients during transition period treated for intracranial tumors and malignancy in childhood- Single center expirence

      ea0099p347
    • Diabetes insipidus and cerebral malaria: a rare etiology to be considered

      ea0099p348
    • Prolactin-related challenges in two critical moments of womens' life: postpartum and menopause

      ea0099p349
    • Assessment of insulin resistance and its associated factors in women with hypopituitarism

      ea0099p350
    • ER stress causes variable ACTH production and secretion in corticotroph tumour cells

      ea0099p351
    • Plasma apelin levels in patients with polyuria-polydipsia syndrome undergoing copeptin stimulation tests

      ea0099p510
    • Assessment of GH/IGF1 axis in relation to pituitary volume and MRI intensity in subjects with obesity: A controlled, cross-sectional, observational study

      ea0099p511
    • Transsphenoidal surgical treatment of symptomatic rathke's cysts. results, follow-up, and recurrence rates

      ea0099p512
    • Novel mutations causing pachydermoperiostosis - hormonal and phenotypic alterations

      ea0099p513
    • A Novel CDKN1B mutation in multiple endocrine neoplasia type 4

      ea0099p514
    • Body weight in acromegaly - does it make any difference?

      ea0099p515
    • Cytokeratin 18: An early biomarker of increased liver fibrosis in newly diagnosed acromegaly

      ea0099p516
    • Management of prolactinomas before, during and after pregnancy: results from the italian association of clinical endocrinologists (AME) survey

      ea0099p517
    • Long-term pharmacotherapy of giant prolactinomas

      ea0099p518
    • Machine learning in differential diagnosis of ACTH-dependent hypercortisolism

      ea0099p519
    • Use of artificial intelligence to predict survival of patients with acromegaly: is it really better?

      ea0099p520
    • Assessing long-term safety and efficacy of osilodrostat in prior- and new-use patients with endogenous cushing's syndrome: a 1-year real-world interim analysis of the non-interventional, multinational LINC 6 study

      ea0099p521
    • Beyond idiopathic arginine vasopressin deficiency: unveiling its etiology after over a decade

      ea0099p522
    • Characterization of patients stopping GH therapy for childhood-onset growth hormone deficiency in belgium - luxemburg

      ea0099p523
    • Differences in the efficacy of second-line therapies on the biochemical control of acromegaly in patients with GH secreting pituitary neuroendocrine tumors (Pit-NETs) and GH and PRL cosecreting Pit-NETs

      ea0099p524
    • Pituitary apoplexy during the SARS-CoV-2 pandemic. role of acute covid-19 and covid vaccination

      ea0099p525
    • Epidemiology of hypothalamic obesity in craniopharyngioma and other rare sellar and suprasellar tumors

      ea0099p526
    • Soluble alpha klotho concentrations are resistant to short-term stimulation and suppression of growth hormone

      ea0099p527
    • Predictors of diabetes remission after surgery in patients with acromegaly. a series of 604 cases

      ea0099p528
    • A peculiar case of ectopic ACTH-syndrome - multiple challenges during diagnostic and therapeutic workup

      ea0099p529
    • The analgesic effect of pasireotide in aggressive, giant pituitary neuroendocrine tumors-case series

      ea0099p530
    • Potential antitumoral effects through modulation of VEGF-A splicing in rat somatotroph and lactotroph pituitary tumoral cells

      ea0099p531
    • Electronic health technologies for comprehensive acromegaly management. preliminary data from a single center experience

      ea0099p532
    • The relations between serum growth hormone, seminal plasma growth hormone, and sperm count in acromegaly patients

      ea0099p533
    • Implications of somatotroph axis in the behaviour of silent corticotroph tumours

      ea0099p534
    • Assessment of endothelial dysfunction in cushing`s syndrome

      ea0099p535
    • Prevalence of steatosis and cardio-metabolic complications in a cohort of adult patients with growth hormone deficiency: a cross-sectional study

      ea0099p536
    • Panhypopituitarism and diabetes mellitus in a woman with HIST1H1E syndrome

      ea0099p537
    • Patient with granulomatous hypophysitis in the course of granulomatosis with polyangiitis (GPA) misdiagnosed as craniopharyngioma

      ea0099p538
    • COVID-19 and hyponatremia: from possibility to probability

      ea0099p539
    • Pituitary apoplexy - a tertiary centre experience

      ea0099p540
    • Complications of transphenoidal surgery for non-producing pituitary adenomas are not related to pretended surgical goals or surgical experience

      ea0099p541
    • DXA-derived lumbar bone strain index corrected for kyphosis is associated with vertebral fractures in acromegaly

      ea0099p542
    • Presentation and treatment response in men with micro, macro or giant prolactinoma

      ea0099p543
    • A case of sporadic metastatic medullary cancer with distant metastases and negative RET mutation

      ea0099p544
    • Effects of recombinant growth hormone treatment on metabolic fitness, body composition and echocardiographic parameters in a population of patients with overweight or obesity and adult GH deficiency

      ea0099p545
    • Pregnancy in a lady with pre-existing cyclical cushing's disease

      ea0099p546
    • The protean manisfestations of erdheim-chester disease

      ea0099p547
    • Effects of MIA-602, GHRH receptor antagonist, on emotional disorders in mice

      ea0099p548
    • Effects of glucagon-like peptide-1 analogs on prolactin: a randomized, double-blind, placebo-controlled crossover trial

      ea0099p549
  • Reproductive and Developmental Endocrinology
  • • Copeptin and oxytocin in MDMA-induced hyponatremia:incidence and severity, mechanisms of action, and the effect of fluid restriction

      ea0099p141
    • Decoding desire: a neurofunctional exploration of distressing low sexual desire reveals sexually dimorphic brain responses

      ea0099p142
    • Receptor-mediated internalisation of the long-acting growth hormone analogue somapacitan in comparison with recombinant human growth hormone and pegvisomant

      ea0099p143
    • Adopted transgender subjects are over represented and have a different psychosocial profile than their non-adopted counterparts: a case-control study

      ea0099p144
    • European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS special interest group's 2023 questionnaire

      ea0099p145
    • The role of menstrual cycle changes in the evaluation of women's reproductive, sexual and mental health - lessons learned from the covid-19 pandemic

      ea0099p146
    • Revised adolescent PCOS criteria: implications for women's metabolic well-being

      ea0099p147
    • Use of combined oral contraceptive pills in women with and without PCOS: A longitudinal population-based cohort study

      ea0099p148
    • The impact of testosterone on TLR expression in transgender men

      ea0099p149
    • Prevalence of polycystic ovary syndrome in women with prediabetes

      ea0099p150
    • Thyroid autoimmunity can negatively influence placental angiogenic factors and hormone secretion

      ea0099p151
    • Comparative analysis of pain characteristics in women with and without endometriosis

      ea0099p152
    • Sexual function, quality of life and gender-related differences in patients with well-differentiated neuroendocrine tumors

      ea0099p153
    • Aromatase inhibitors and abrupt increase obesity rates among in males during puberty

      ea0099p154
    • Diagnosis experiences in an international sample of lean women with PCOS

      ea0099p207
    • The impact of motivational interviews and hospitalization in themanagement of obesity associated infertility

      ea0099p211
    • Early response with fezolinetant treatment of moderate-to-severe vasomotor symptoms associated with menopause in women considered unsuitable for hormone therapy: phase 3b daylight study

      ea0099p352
    • Renal 11[beta]-hydroxysteroid dehydrogenase type 2 is of central importance for 11-oxygenated androgen biosynthesis and is disrupted in chronic kidney disease

      ea0099p353
    • Abstract unavailable

      ea0099p354
    • Gonadal and sexual function in men living with HIV: a real-life single centre experience

      ea0099p355
    • Clinical, biological and socio-professional characteristics of patients harboring the 46,XX/47,XXY mosaic sex chromosome aneuploidy: the MOSAI-XX multicenter study

      ea0099p356
    • Regulation of PGR gene expression in immortalized human endometrial stromal cells

      ea0099p357
    • Congenital hypogonadotropic hypogonadism by PNPLA6 mutations: identification of a wide phenotypic spectrum and functional correlations with the NTE in vitro activity

      ea0099p358
    • Expression of the serotonin signaling pathway in a testicular adrenal rest tumor in a patient with 21-hydroxylase deficiency

      ea0099p359
    • Different adipose tissue depots: metabolic implications in polycystic ovary syndrome

      ea0099p360
    • Prenatal testosterone exposure and offspring body composition at 7 years-of-age. odense child cohort

      ea0099p361
    • Mental health and illness uncertainty of individuals with polycystic ovarian syndrome: how is the quality of life affected?

      ea0099p362
    • A multinational study to explore the management of dermatological manifestations associated with polycystic ovary syndrome (PCOS) across europe

      ea0099p363
    • The risk of obesity and metabolic complications in hyperandrogenic physically inactive young women with PCOS

      ea0099p364
    • Early changes in muscle strength and body composition under gender-affirming hormonal therapy in transgender people assigned female at birth

      ea0099p365
    • [ldquo]Brief intelligence test[rdquo] questionnaire in klinefelter syndrome: may words improve diagnosis?

      ea0099p366
    • Comprehensive WES reanalysis of rare endocrine patients for the identification of novel disease-causing genes

      ea0099p550
    • Endocrine responses to kisspeptin in an unusual case of kallmann syndrome with unilateral anosmia

      ea0099p551
    • Hypoechoic testicular lesions in klinefelter syndrome show volumetric reduction in response to testosterone therapy

      ea0099p552
    • Patient and public involvement in simulation via instant messaging - birmingham advance (SIMBA) training improves clinicians' confidence in managing reproductive endocrinology cases

      ea0099p553
    • Revitalizing kidney health in polycystic ovary syndrome: a novel approach— targeting STAT3 signaling for restored mitochondrial function and reduced kidney injury

      ea0099p554
    • Klinefelter syndrome is associated with early-onset metabolic defects that are not reversed by testosterone therapy

      ea0099p555
    • 4 Cases of postmenopausal hyperandrogenism in glasgow

      ea0099p556
    • MiRNAs specific for PCOS phenotypes

      ea0099p557
    • Anti-Mullerian hormone as a predictor of ovarian function in patients undergoing radioiodine treatment for thyroid cancer

      ea0099p558
    • Assesing the proficiency and alignment of ChatGPT 3.5 responses with guidelines in addressing frequently asked questions by transgender individuals

      ea0099p559
    • Dampened HPG axis activity and improved reproductive lifespan in dummerstorf superfertile mouse lines

      ea0099p560
    • In vitro analysis of FSHR internalization and signalling mediated by two different FSH preparations

      ea0099p561
    • Assessment of muscle mass and strength in women with PCOS following oral contraceptive therapy

      ea0099p562
    • Investigation of circulating androgens' circadian variations: expanding the knowledge by monitoring phase II metabolites

      ea0099p563
  • Thyroid
  • • Low TPO-antibody titers appear to promote aggressive thyroid cancers tumorigenesis: analysis of a large multinational dataset

      ea0099p155
    • Thyroid hormone transporter Mct8/Oatp1c1 deficient mice display impaired CNS capillary network formation

      ea0099p156
    • Plasmablastic lymphoma presenting as a rapidly increasing thyroid mass: a case report

      ea0099p157
    • Subacute thyroiditis in the SARS-Cov-2 era: a multicenter prospective study

      ea0099p158
    • Transcriptomic characterization of single cells derived from immortalized human thyroid follicular epithelial cell lines

      ea0099p159
    • New plasma biomarkers: XIAP and survivin in patients with medullary thyroid cancer (MTC)

      ea0099p160
    • Differentiated thyroid cancer in pregnancy. A retrospective analysis of newly diagnosed patients

      ea0099p161
    • Falsely elevated thyroid function tests due to laboratory interference

      ea0099p162
    • The effect of monoclonal antibodies alemtuzumab and ocrelizumab on the thyroid function of patients with multiple sclerosis

      ea0099p163
    • High local and systemic expression of pentraxin-3 in anaplastic thyroid cancer

      ea0099p164
    • Clinical and histopathological factors associated with the prognosis of medullary thyroid cancer in a tertiary center

      ea0099p165
    • Graves' disease relapse after 30-year remission in a female patient due to SARS-CoV-2 infection- a case report

      ea0099p166
    • Characterizing TSH-receptor antibody (TRAb) seropositive and TRAb seronegative patients with Graves hyperthyroidism - a cross-sectional study

      ea0099p167
    • Thyrotoxicosis and thyrotoxic periodic paralysis in hong kong: a population-based cohort study

      ea0099p168
    • Determination of the relationship between the development of persistent hypothyroidism after subacute thyroiditis and subtypes of human leukocyte antigen

      ea0099p169
    • Reference range and determinants of serum thyroglobulin in southwestern greece

      ea0099p170
    • Diagnosis of medullary thyroid microcarcinoma by calcitonin measurement in fine-needle aspiration washout

      ea0099p171
    • Safety of primary care-led surveillance for low-risk thyroid cancer patients

      ea0099p172
    • Thyroid health in inflammatory bowel disease

      ea0099p173
    • Changes of lipid profile in subclinical hyperthyroidism and following restoration of euthyroidism

      ea0099p174
    • ALK fusion genes in a large cohort of thyroid carcinomas

      ea0099p367
    • Long-term gene expression changes in the rat thyroid by neonatal irradiation - a possible mechanism related to thyroid carcinogenesis by childhood radiation

      ea0099p368
    • The association of gestational thyroid function and thyroid autoimmunity with offspring neurodevelopment: an individual participant meta-analysis

      ea0099p369
    • Clinical value of reverse triiodothyronine in the identification of euthyroid sick syndrome and prediction of mortality in critically ill patients

      ea0099p370
    • Papillary thyroid cancer and body mass index: the role of mitochondrial arginase-2 in tumor microenvironment

      ea0099p371
    • Diagnosis and therapy of medullary thyroid cancer. A real-life, retrospective, multicentric, Hungarian study

      ea0099p372
    • Women-specific reference ranges for serum TSH in Liguria: the impact of age and time of collection in a single-centre cross-sectional study

      ea0099p373
    • Adolescent with multiple benign skin lesions, cutaneous angiosarcoma and multiple thyroid nodules. what is the diagnosis?

      ea0099p374
    • Complications associated with the performance of thyroidectomies in a third-level hospital

      ea0099p375
    • PTEN variants in thyroid tumors of czech patients

      ea0099p376
    • Characterization of a series of 661 papillary throid microcarcinoma with excellent response to treatment

      ea0099p377
    • Ocular myasthenia gravis and sub clinical hyperthyroidism- a rare occurrence

      ea0099p378
    • Autoimmune endocrinopathies in patients with relapsing and remitting multiple sclerosis

      ea0099p379
    • Interrelationships between thyroid function, autoimmunity, low-grade inflammation, lipid profile and insulin resistance in graves' disease

      ea0099p380
    • Serum CD5L as potential biomarker of thyroid hormone status during pregnancy

      ea0099p381
    • Antithrombotic/anticoagulant drugs did not increased the risck of bleeding during thyroid fna (nor it´s whithdrawal up to one month reduced it´s risk)

      ea0099p382
    • Simultaneous presentation of thyrotoxicosis and diabetic ketoacidosis in two previously healthy men

      ea0099p383
    • Echocardiographic differences between the mild form of subclinical hypothyroidism and healthy subjects

      ea0099p384
    • hCG-TSHR cross-interaction: a rationale for in hyperemesis gravidarum?

      ea0099p385
    • Pathogenic variants of CHEK2 gene in thyroid cancer (TC) patients with a personal and/or familial history of other malignancies

      ea0099p564
    • Molecular characterization of circulating tumor cells (CTCs) in sporadic medullary thyroid carcinoma (spMTC) patients

      ea0099p565
    • Modified systemic inflammation score for prediction of malignancy in indeterminate thyroid nodules- an effective tool in low-resource settings!

      ea0099p566
    • Genetic and environmental factors in autoimmune thyroid disease: exploring the associations with selenium levels and novel genetic loci in a latvian cohort

      ea0099p567
    • Long-term outcomes in children and young adults with graves' disease

      ea0099p568
    • Thyroid core-needle biopsy. first experience in romania. 281 cases with only 1% non-diagnostic results

      ea0099p569
    • Impact of the introduction of minimally invasive treatments of the thyroid (MITT) for benign thyroid nodules in an italian hospital: a cost-minimization analysis

      ea0099p570
    • Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study

      ea0099p571
    • Regulatory T and B cells in autoimmune thyroiditis

      ea0099p572
    • Focal thyroid incidentalomas in 18F-PSMA PET/CT - a retrospective analysis of incidence and clinical significance

      ea0099p573
    • Thyrotoxicosis in metastatic choreocarcinoma

      ea0099p574
    • Endoscopic ultrasound guided fine needle aspiration (EUS-FNA) with aspirate parathormone (PTH): a case report and review of the literature

      ea0099p575
    • Radiofrequency ablation is an effective treatment for bethesda iii nodules without genetic alterations

      ea0099p576
    • Using routine laboratory results to establish valid thyroid reference values

      ea0099p577
    • 12-month outcome with microwave ablation in benign thyroid nodules

      ea0099p578
    • Is autoimmune thyroiditis in females with ehlers-danlos syndrome associated with lower bone density?

      ea0099p579
    • Correlation between the expected risk of malignancy according to FNA and the actual percentage of malignancy found on pathological anatomy in thyroidectomies and hemithyroidectomies

      ea0099p580
    • Thyroid function might decrease after adjuvant chemotherapy in postmenopausal women with early breast cancer

      ea0099p581
    • Epidemiology of primary hypothyroidism in the republic of moldova

      ea0099p582
  • Late-Breaking
  • • Novel homozygous pathogenic variant in the Vitamin-D binding protein in a patient with undetectable Vitamin D levels despite treatment with high doses of vitamin D

      ea0099p175
    • [18F]FET PET-MRI; A diagnostic tool to improve medical decision-making for small functioning pituitary adenomas in acromegaly patients

      ea0099p176
    • Patient profile of asymptomatic primary hyperparathyroidism (APHPT) at tertiary care riga east clinical university hospital

      ea0099p177
    • TNXB genotype and serum levels in individuals with and without congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0099p178
    • Mortality in young women with turner syndrome is mainly due to aortic dissection - a 25-year follow-up in sweden

      ea0099p179
    • Immunohistochemistry in the differential diagnosis of atypical tumor and parathyroid carcinoma

      ea0099p180
    • The relationship between glycated hemoglobin and glycemic variability in type 1 diabetics

      ea0099p181
    • Sticks and stones could break my bones: a rare case of adult hypophosphatasia (HPP) at 24 weeks of pregnancy

      ea0099p182
    • Clinical spectrum associated with variants in the ins gene in patients with suspected monogenic diabetes

      ea0099p183
    • We used to be identical twins! a tale of MEN-1 and gigantism: the identical twin 1 foot taller than his brother

      ea0099p184
    • Spectacular liver tests improvement during osilodrostat treatment in patient with cushing syndrome and impaired liver function

      ea0099p185
    • Integrated analysis of fecal metagenomics and serum metabolomics reveals the role of gut microbiome-associated metabolites in detecting gestational diabetes mellitus

      ea0099p186
    • Radiological diagnosis of atypical femoral fractures using qualitative and quantitative criteria: a retrospective cohort analysis across two centres over 10 years

      ea0099p187
    • Relationship of lipoprotein-a levels with the metabolic profile, bone status and kidney function in patients with type 1 diabetes

      ea0099p188
    • Advanced liver fibrosis is associated with the presence of type 2 diabetes rather than body mass index

      ea0099p189
    • Severe osteoporosis in a patient with APECED: atypical presentation

      ea0099p190
    • Activating somatic ESR1 mutation in an aggressive prolactinoma

      ea0099p191
    • Effectiveness of myo-inositol in treating infertility in patients with polycystic ovary syndrome

      ea0099p192
    • A patient with an adrenal adenoma and pituitary and intracranial meningiomas due to an ARMC5 mutation

      ea0099p193
    • Metastatic pulmonary neuroendocrine carcinoma associated with AVP deficiency and panhypopituitarism due to a hypothalamic metastasis

      ea0099p194
    • Age-stratified reference ranges for directly measured serum free testosterone in healthy men

      ea0099p195
    • Assessing medication adherence and unravelling the reasons for non-adherence among patients with diabetes mellitus

      ea0099p196
    • Improving the inpatient assessment and management of people with diabetes and frailty by the involvement of the diabetes in reach team

      ea0099p197
    • Comparing analytical and glucometric parameters in patients with type 1 diabetes

      ea0099p198
    • Endocrine toxicity is an independent predictor of survival in lung cancer patients treated with immune checkpoint inhibitors

      ea0099p199
    • The association between levels of Follicle stimulating hormone and Glomerular filtration rate in peri- and postmenopausal women

      ea0099p200
    • Molecular genetics of unresolved mody (Mody-X)

      ea0099p386
    • Gemigliptin attenuates TGF-[beta]-induced renal fibrosis by inhibiting the TGF-[beta]/Smad3 signaling pathway through the upregulation of FGF21 expression

      ea0099p387
    • Is thyroid function associated with polycystic ovary syndrome? a bidirectional mendelian randomization study

      ea0099p388
    • Effect of endothelial no synthase gene polymorphism on the course of diabetic nephropathy in patients with type 2 diabetes mellitus

      ea0099p389
    • Progression of joint and psychological complications in acromegaly and their association with treatments and disease control

      ea0099p390
    • Surgical outcomes in primary hyperparathyroidism: addressing factors predicting persistent or recurrent hyperparathyroidism

      ea0099p391
    • Evaluation of 8-oxo-2'-deoxyguanosine as a surrogate marker of NF-κB/NLRP3 axis activation in experimental diabetes mellitus

      ea0099p392
    • Beware of the imposter! A case report of pseudopseudohypoparathyroidism in Trinidad and Tobago

      ea0099p393
    • LC/MS untargeted lipidomics analysis in women with morbid obesity and type 2 diabetes mellitus: a comprehensive study

      ea0099p394
    • Effect of Mediterranean diet on quality of life and disease burden in patients with Hashimoto's thyroiditis

      ea0099p395
    • Growth hormone-releasing hormone (GHRH) antagonists enhance radiosensitivity in non-small cell lung cancer cells

      ea0099p396
    • Reversible and late-onset adrenal insufficiency in survivors of COVID19: results from a 24-month longitudinal study

      ea0099p397
    • GIP receptor is expressed by human cumulus granulosa cells

      ea0099p398
    • Persistent parathyroid hormone elevation post-parathyroidectomy with biological remission: prevalence and predictive factors

      ea0099p399
    • Diabetes prevalence and impact on stroke outcomes: an analytical study

      ea0099p400
    • Pituitary dysfunction following mild traumatic brain injury in female athletes: neuropsychological and psychological functioning

      ea0099p401
    • Gonadis national registry on gonadal status in pituitary and adrenal disorders: prevalence and characterization of testicular morpho-structural and reproductive alterations in male patients with congenital adrenal hyperplasia

      ea0099p402
    • LIMK1 variants are associated with divergent endocrinological phenotypes aligning with divergently altered exocytosis dynamics.

      ea0099p403
    • Weaning patients off long-term low dose prednisolone: an international survey of current endocrine practice

      ea0099p404
    • Unexpected diagnosis of a mixed corticomedullary tumor of the adrenal gland in a hypertensive patient with unexplained weight loss

      ea0099p405
    • The phenomenon of macro-TSH in a patient on oncoimmunotherapy: a clinical case report

      ea0099p406
    • Schmidt's syndrome: think about it in males too: A case report

      ea0099p407
    • The impact of the acromegalic arthropathy on daily functioning in patients with acromegaly

      ea0099p408
    • Increased cardiovascular risk in sheehan syndrome patients on optimal hormonal replacement therapy- a case-control study

      ea0099p409
    • Cardiovascular evaluation of the patients with sleep apnea syndrome and acromegaly: A prospective study on the effects of continuous positive airway pressure (CPAP) therapy

      ea0099p410
    • Prevalence of hepatosteatosis in young women with polycystic ovary syndrome (PCOS)

      ea0099p411
    • Twelve years of experience using teriparatide for severe hypoparathyroidism in an APS-1 patient: a case report

      ea0099p583
    • Long-term bone health in women with a premenopausal risk-reducing salpingo-oophorectomy (RRSO) compared with women who underwent

      ea0099p584
    • Vitamin D and quality of life in patients with hashimoto thyroiditis

      ea0099p585
    • Clinical presentation of sporadic and familial medullary thyroid carcinoma: is there a real difference?

      ea0099p586
    • Primary hyperparathyroidism: the relationship between serum calcium levels and renal function before and after curative surgery

      ea0099p587
    • Psychiatric comorbidities in chronic hypoparathyroidism - a german single-center analysis in 133 patients

      ea0099p588
    • The prevalence, distribution and use of analgesics for arthropat